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ABSTRACT

ZINC-MEDIATED DIMERIZATION OF PROTEINS THROUGH A
–CxCxxxxCxC– SEQUENCE

By
Tyler Christian Collins
December 2009

Dissertation supervised by Professor Charles T. Dameron
Dimerization of cellular proteins has become an intense field of study due to its
importance in signal transduction and gene expression, amongst many other functions.
Arguably the most intriguing quality regarding dimerization is the high incidence of
simultaneous dimeric events occurring within the cell, where each constructed dimer
individually controls a single pathway with high specificity. Additionally, the
discoveries of new motifs possessing this seemingly common functionality participate in
truly unique and often poorly understood mechanisms. CopY, a metal-responsive
bacterial repressor from Enterococcus hirae possesses distinctive dimerization properties.
We show that this cysteine metal-binding motif, which contains a metal-reactive Cterminal –CxCxxxxCxC- site used for sensing high Cu(I), is also indispensible for dimer
formation in its Zn(II) form in vivo and in vitro. Paired adjacent to the cysteine motif is a
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repeating aliphatic sequence that mimics a coiled-coil, where the two combined
contributors produce a dimer of low micromolar affinity. Removal of the metal-binding
site perturbs the dimer’s stability, resulting in the loss of specific two-stranded
dimerization and shifting the complexes equilibrium towards an aggregated state
according to isothermal titration calorimetry. This transition illuminates the site’s role in
organizing quaternary structure. Protein-fragment complementation assay technology
was employed to explore the whole dimer’s ability to heterodimerize in an effort to
establish the level of specificity within the aliphatic-repeat sequence. The results indicate
that symmetrical deletions within the aliphatic-repeat produce stronger dimers compared
to those asymmetrically constructed. In all cases, metal-binding site was necessary for
successful construction of high-affinity dimers according to both methods.
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Chapter 1
Introduction

1.1. Metals Participate in Specific Protein-Protein Interactions
The quaternary structure of proteins varies substantially across biology, ranging from
stably-constructed protein lattices, to rapid signaling cascades which rely on proteinprotein recognition1-3. A phenomenon which accounts for many biological events within
the cell, protein-protein interactions control the survival and health of all organisms
living on the planet. Protein-protein interactions can be globally defined through the use
of either individual or groups of amino acid residues originating from two or more
separate proteins which form reversible or irreversible bonds which each other1-3.
Typically, specificity is built within a residue or a sequence of residues that participate in
the interaction, or in the general architecture of a motif which harbors those residues so
the desired pathway is properly signaled. The larger configurations formed from the
construction of protein-protein interactions may generally function as cellular support
structures, scaffolds for recruiting other proteins in a cooperative manner, or as switches
which govern downstream signaling pathways4, 5. Protein-protein interactions can be
used in more application-based scenarios, such as medical diagnostics, kit-based
molecular biology techniques which induce dimerization or as targets to create drugs.
This research aims to investigate the relation between the coordination of metal ions
within proteins, and its influence upon the formation of dimers.
1

The class of proteins that directly control metal detoxification systems in bacteria are
metal-sensing repressors. Metal-responsive transcription factors function through
sensing of the specific metal in excess. To maintain homeostasis, the cell is signaled to
counteract toxicity through the expression of detoxifying proteins built specifically to
bind the particular metal6, 7. Upon metal-binding to the repressor, conformational
changes in global structure are produced through the rearrangement of bonds to
accommodate the metal, therefore disrupting protein-nucleic acid interactions8.
Seemingly miniscule changes in the coordination geometry within a protein induce larger
cellular responses which enable a cell to react quickly in order to regain equilibrium. The
reality is that several metal-sensing repressors are responding simultaneously to deficits
or surpluses of toxic metals at any time. Specificity of the metals bound to the governing
repressors allows the cell to cope with possibly toxic levels of multiple metal ions at
once. Understanding each dimeric interaction within the cell helps establish how vital
specificity is to the survival of the cell and as a consequence, whole organisms.
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1.2. Examples of Metal-Responsive Dimerization: The Focus of this
Research
The family of metalloregulatory proteins being reviewed is identified as
prokaryotic metal-sensory transcriptional activators. The metal-sensing family of
transcriptional repressors controls the production of proteins in charge of the removal of
specific metal ions when in excessive cellular concentrations. Such bacterial systems
exist for Cd(II), Pb(II), Co(II), Ni(II), Zn(II) and Cu(I) to name a few9, 10. Specificity
with regard to the correct binding of metal to its parent regulatory repressor is critical for
the cell to survive and maintain homeostasis. Systems such as these originating from
bacterial pathogens are arduously studied as understanding these pathways may lead
towards new antimicrobial drug targets.
The process of molecular recognition of metal ions in the cell must be tightly
regulated in order to fulfill cellular requirements without initiating oxidative stress11. The
cell possesses pathways that circumvent the potential problems which arise regarding the
specificity metal-ion binding to its macromolecular target. Protein-protein interactions
facilitate the specificity associated with the introduction, trafficking and regulation of
metal ions within the cell12, 13. For instance, import and export pumps embedded in the
cellular membrane serve as transporters which can negotiate the specificity of binding the
correct ion based upon nuclei diameter, charge and other elemental parameters13-15. From
the moment the correct ion enters the cytoplasm, protein-protein interactions govern its
intracellular fate, whether it be motioned towards a specific enzyme for structural,
catalytic or redox purposes, or to activate its own metabolism11, 13, 15. The dialogue to
follow will focus upon those promoter-bound regulatory elements which exist as
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homodimers when affixed to their nucleic-acid recognition sequence. A common feature
of prokaryotic metallo-regulatory repressors is that the activating metal-binding sites lie
at the dimerization interface7, 16, 17. Ligands responsible for coordinating these metal ions
are usually cysteinyl thiolates where binding of a single ion may utilize thiolates from
only one monomer or from both.

1.3. CopY from Enterococcus hirae: A Unique Metallo-Regulatory Protein
The CopY protein from Enterococcus hirae, a gram-positive bacterium, is an
example of a complicated quaternary protein fold, utilized within a unicellular bacterium.
Better known as a paradigm for copper homeostasis, the E. hirae copper system deserves
more detailed attention regarding how each participant functions the way it does12, 15.
Metal-responsive repressors are extremely important due to their relationship in
controlling the concentration of radical-inducing metals that enter the cell, which makes
CopY an attractive example as a metal sensor.

1.3.1. CopY’s Involvement in Prokaryotic Copper Metabolism
CopY is a metal-requiring repressor protein of the cop operon in E. hirae,
controlling the expression of four indispensable cop proteins13, 15, 18, 19. Together, all four
proteins CopY, CopZ, a Cu(I) chaperone, and membrane-spanning ATPases CopA and
CopB, function in maintaining Cu(I) concentrations at functional, non-toxic levels7, 8, 12.
Generally, CopY requires one bound Zn(II) per monomer within its C-terminal metal
binding site which is comprised of four cysteines in a –CxCxxxxCxC– amino acid motif7,
8, 13, 20

. It is hypothesized that the Zn(II) is necessary for initial dimer formation and to
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provide the metal binding site with the correct structure in order to accept two Cu(I)
ions15, 19. Upon the influx of metal, two moles of Cu(I) displace the one Zn(II) within
CopY’s metal binding site8, 13, 15. Metal-induced transformation subsequently disrupts the
repressor’s affinity for the cop promoter and also relaxes the metal binding motif’s
backbone to accommodate two Cu(I) in place of one Zn(II)6, 13, 21-23. Previously, its
dimerization contains contributions from its metal-binding site and four adjacent β–
branched hydrophobic residues. The series of four leucine and isoleucine residues is part
of a larger sequence containing hydrophobic residues evenly-spaced apart. The whole
region, termed an aliphatic-repeat, has not been investigated with regard to whole
contributions to CopY’s dimerization. Although CopY metal binding site is distinct with
respect to how it reacts to changes in cellular metal influx, there are other regions of the
protein which may influence its dimerization.

1.3.2. CopY Function and Domain Composition
CopY is a regulatory protein that can adopt one of two metal-binding
arrangements within its –CxCxxxxCxC- site, where its metal coordination governs its
DNA-binding functionality6-8, 24. In its promoter-bound “repressed” state, one zinc(II)
occupies the CopY metal binding motif in a tetrahedral metal-thiolate configuration7, 15.
Averaged metal-thiolate bond distances have been measured using extended x-ray
absorption fine structure (EXAFS) spectroscopy, confirming the metal-binding location
of Zn(II) or Cu(I) in CopY’s C-terminus15. CopY’s promoter-induced state produces a
conformation change resultant from the replacement of its bound Zn(II) with two moles
of Cu(I) from the CopZ chaperone15, 21, 25, 26. EXAFS was used to measure the average
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bond distances between both metal-thiolate bonds and bonds between metal ions15. All
current studies suggest an indispensable role for CopY’s metal binding motif for
regulating its intracellular Cu(I), but reports are not available on CopY’s metal-regulated
dimerization capabilities. Recently, it has been hypothesized that other regions of CopY
may also participate in stabilizing the dimer.
The aliphatic repeat is composed of a series of β-branched aliphatic amino acids
such as leucine, isoleucine and valine, spaced in a fashion that approximates a welldocumented alpha-helical motif known as a coiled-coil. Stabilization of the coiled coil
motif is created through exterior salt bridge formation via oppositely-charged residues
which effectively shields the buried aliphatic interior of the hydrophobic core. Coiledcoils produce pairwise, or higher order protein-interactions driven by hydrophobic
effect27-29. Typically characterized in terms of heptad repeats, hpphppp would represent
such a primary sequence where “h” represents a hydrophobic amino acid such as a
leucine, isoleucine or valine where “p” represents a polar residue30-32. Having a series of
heptads present within an alpha helix would produce an amphipathic structure with a
stripe of hydrophobic residues lying on one side.30-32 Combining the latter and its metal
binding motif, the C-terminal half of CopY is hypothesized to form its dimerization
domain. Therefore, the hypothesis states that both the metal-binding site and the
aliphatic-repeat contribute to the formation of dimers.
It has been determined that the C-terminal 38 residues of the CopY repressor are
sufficient to preserve dimerization of proteins for which it is attached 19. This section of
the repressor includes 25 amino acids of aliphatic repeat which include 4-leucine repeats,
and its metal-binding motif. In this specific construct, mutation of these four stabilizing
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residues does not completely abolish dimerization of the 38-mer19. What does abolish
dimerization is the combination of the latter, combined with the irreversible modification
of the 38-mer’s Zn(II)- and Cu(I)-coordinating cysteines 19. Since it is evident that the
metal-binding motif is key towards maintaining dimerization, determination of those
regions contributing affinity is necessary.
Spanning as much as 95 residues, CopY’s N-terminal 60 residues can be defined
as its DNA-binding domain15. The DNA-binding domain has been characterized based
upon DNase footprinting experiments along with homology modeling of other DNAbinding repressor proteins such as the λCro repressor from bacteriophage6, 15. Such
protein folds have been grouped as penicillinase repressors which possess helix-turnhelix motifs33. In addition, CopY forms a winged helix motif sharing high homology
with BlaI and MecI from S. aureus, along with B. licheniformis PenI15, 20, 34. The research
presented hereafter focuses on the C-terminal 95 CopY residues that have been
designated its dimerization domain. Most importantly, the CopY repressor from E. hirae
is not one-of-a-kind, as other unicellular organisms possess close homologs, all of which
have a similar metal binding motif and an aliphatic repeat region of diverse length.

1.3.3. Other Organisms Possessing Similar “Dimerization Domains”
Generally, CopY belongs to the penicillinase superfamily of bacterial repressors
such as the popular β-lactamase repressor used commonly in the biomedical research
field to enforce antibiotic resistance in host recombinant bacteria15, 35. More specifically,
CopY belongs to the BlaI/MecI family of transcriptional repressors based upon sequence
similarity36-38. However, functionally, CopY coincides with the ArsR/SmtB family of
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metal-sensing repressor proteins. Such a repressor from E. faecalis shares 94% amino
acid homology (84% identity) to CopY, making it CopY’s closest ancestor.
The CopY protein can be found in other organisms using the Basic Local
Alignment Search Tool (BLAST) from the National Center for Biotechnology
Information (NCBI)39. The majority of proteins which share greater than 50% homology
with CopY are located within the gram-positive division of the firmicutes bacterial
phylum. Such bacterial species possessing similar whole CopY repressors with cysteinerich metal-binding sites are Enterococcus faecalis, Lactobacillus actei, Streptococcus
pyogenes, Streptococcus alagactiae, Streptococcus thermophilus and Streptococcus suis.
Some of these species are not harmful (e.g. S. thermophilus), whereas a number of others
(e.g. E. hirae, E. faecalis, S. suis, S. agalactiae, S. pyogenes) are pathogenic.
Homologs of CopY’s C-terminal metal binding site can be found across a wide
range of proteins from various species. The –CxCx4CxC- motif is observed in many
different protein classifications such as transporters, heat shock proteins, interleukin
variants and GTPase activators according to NCBI’s BLAST program. As a result,
hundreds of proteins result from a search of only the CopY metal-binding site. An
expanded search including an aliphatic-repeat region adjacent to the metal-binding site
produced more detailed results that include proteins that share common functionality.
One surprising result included the human glutamate decarboxylase 2 enzyme that
contains an N-terminal –CxCx4-5CxC- and an adjacent aliphatic-repeat region40. Its
crystal structure (PDB ID: 2OKK) does not provide any structural detail of the –
CxCxxxxCxC- site since it was removed from its gene sequence prior to purifying and
crystallizing the enzyme. Initial attempts at crystallizing the full-length enzyme produced
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poor X-ray crystallographic resolution within its N-terminus, therefore its first 88
residues were removed40.
Investigation into GAD2’s ability to bind Zn(II) and create dimers in vitro
commenced upon acquisition of the bacterial plasmid containing the full-length GAD2
sequence including the cysteine motif. Preliminary tests on the whole enzyme
undertaken in the Dameron laboratory showed inhibition of its activity with the addition
of Zn(II) to the assay (unpublished observations). Analysis of the enzyme’s ability to
dimerize is currently being done in an effort to show the metal-binding site and its
adjacent aliphatic-repeat produce specific protein-protein interactions across protein type
and phyla.

1.4. Other Analogous Metal-Sensory Proteins
Based upon its structural topology, CopY belongs to the penicillinase-based
BlaI/MecI/CopY family of winged-helix repressors34, 35, 37. Winged helix proteins
possess a characteristic helix-turn-helix DNA binding motif that interacts with the major
groove of DNA, allowing repressors within the family to control gene expression34.
CopY belongs to the penicillinase family of repressors based strongly upon its primary
structural high homology to BlaI and other members41. However, CopY’s functionality
relies on its ability to sense high levels of Cu(I) within E. hirae, making it functionally
similar to other metal-sensing repressors within the SmtB/ArsR family of proteins.
Specifically, metal-derepressors found within many pathogenic bacteria such as
Mycobacterium tuberculosis, Bacillus subtilis, and cyanobacteria contain metal-sensory
abilities42, 43. Often times within the family of repressors, the metal-binding sites reside
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within the interface of the homodimer where bridging ligands originate from each half of
the dimer44. Metal detoxification systems for Zn(II), Cu(I), Ni(II), Pb(II), Co(II), Cd(II),
As(II) and Fe(II) depend on metal-responsive homodimers in order to control the
biosynthesis of proteins related to their metabolism36, 45, 46.
Metal derepression is the most common form of transcriptional factor control of
the production of metal detoxifying proteins 36, 45. Metal derepression utilizes metalbinding to up-regulate the production of extrusion proteins in order to detoxify the cell36,
45

. Typically, these systems require the controlling repressor to bind the

operator/promoter sequence of the downstream genes in order to inhibit protein
biosynthesis36, 45. Once induced through metal-binding at high concentrations, the cell
regains homeostasis through the efflux of excessive metal36, 45. Repressors retaining this
functionality include ArsR, SmtB, CsoR and CopY42, 44, 47. Conversely, metal corepressors down-regulate the uptake and import of metal ions within the cell. Repressor
proteins fitting this description include Fur, NikR and DtxR36, 45. Examples of both
metal-derepressors and metal co-repressors will be reviewed to highlight those
characteristics similar to CopY in protein structure, metal-binding and dimerization.

1.4.1. The Cadmium(II) Responsive Repressor CadC
The Staphylococcus aureus CadC protein is a metal-inducible repressor
responsible for the detoxification of Pb(II), Cd(II) and Zn(II)17, 48. Binding of any one of
the aforementioned metals to CadC activates a membrane-spanning efflux pump to
remove excessive concentrations of the metal17, 48. Generally, CadC acts as a heavy-
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metal sensor for the cell when the presence of toxic metals becomes too great, the
negative transcriptional regulator will dissociate from the cadCA operon to produce the
CadA P-type metal-extrusion ATPase17. In its repressed DNA-bound state, CadC binds
across the cadC/A operator/promoter region in its apo form, contrary to CopY which is a
Zn(II)-requiring repressor. Once CadC is derepressed, the expression of CadA confers
resistance to either excess Cd(II), Zn(II) or Pb(II) and facilitates its removal.
There are several noteworthy similarities between CadC and CopY. For example,
both repressor proteins belong to the winged-helix/helix-turn-helix family of repressors
which contribute to each protein’s DNA-repressive capabilities48. Also, both proteins are
found in gram-positive bacteria. Most importantly, CadC and CopY both possess a
cysteine-rich, metal binding site inducible through the coordination of either Cu(I) for
CopY, or Pb(II), Cd(II) or Zn(II) for CadC9, 17, 48.
Being a symmetrical dimer, each CadC monomer possesses two metal-binding
sites, one regulatory site composed of all cysteines and its non-regulatory site constructed
of residues from both monomers across its dimer interface9,49, 50. The details of CadC’s
dimerization are found in Figure 1.1. Its regulatory site which binds Cd(II) and Zn(II) is
reliant upon Cys7, Cys58, Cys60 and the Cys11 residue, which is not obligatory49, 50. Its
non-regulatory site, found to bind Zn(II) and Co(II), is not critical towards homodimer
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Figure 1.1. Crystal Structure of the CadC Repressor (1U2W).
The metal-responsive, homodimeric CadC repressor is depicted in ribbon format9.
Each subunit is represented by either green or purple. Zinc is indicated by blue
spheres. When crystallized and solved, its asymmetric unit included four subunits, or
two separate dimers. Shown above is the doubly-metallated Zn(II) dimer in Panel A.
Hydrophobic interactions account for the majority of the stability where the
coordinated Zn(II) at opposite ends of the α3/α5 helix might increase dimer affinity,
as indicated in the top panel structure. The two Zn(II) cations are bound to the nonregulatory sites of the dimer. Panel B depicts the metalated dimer in Panel A rotated
by 90°, where the bottom surface of the dimer would bind DNA within the major
groove.
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binding with subsequent preservation of dimerization, to the bond distances between
thiolate ligands and coordinate metals, CopY and CadC both share similar global folds
and functions, along with intracellular mechanisms that efficiently control Cu(I) and
Cd(II), respectively.

1.4.2. The Zinc-Responsive Homodimer SmtB
Originating from a Synechococcus PCC7942 plasmid composed of transition
metal resistance genes, the SmtB protein is a trans-acting metallothonein repressor that
binds Zn(II) and Cd(II)47, 51. SmtB’s α + β topology produces a classic helix-turn-helix
motif, similar to the aforementioned CadC and this project’s target CopY repressor52.
Based on homology, SmtB has also been placed in a family of winged-helix, metalloregulatory repressors with CadC and the arsenic-resistance repressor ArsR from
Escherichia coli52. Consequently, SmtB does not adapt a metallated form like CopY
while in its nucleic-acid bound form, but remains apo until activated by an influx of
Zn(II)43. Figure 1.2 contains a structure of the apo-SmtB repressor.
Each subunit possesses one empty metal binding site positioned at the C-terminus,
easily solvent accessible to bind metal44, 45. Similar to CadC, in its dimeric DNA-bound
form, two additional sites are created at the interface of dimerization51. Upon activation
of SmtB, the influx of Zn(II) binds and derepresses the operon, signaling for its release
from the cell36. Unlike CadC, SmtB’s regulatory site is pointed away from the dimer
interface36, 44. Each SmtB monomer’s N-terminal metal-binding located on the α3 helix
is not inductive, however the C-terminal α5 helix is responsible for repressor
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Figure 1.2. Crystal Structure of the Zn(II)-Responsive SmtB Repressor (1SMT).
The Zn(II) responsive metallothionein SmtB repressor from Synechococcus elongates
rendered in Jmol53, 54. Crystallized as an apo protein, the repressor is known to have a
total of four Zn(II) binding sites between the two subunits; two at flanking ends of the
dimer and two along the dimer interface. SmtB is known to have homology to CopY
through its shared helix-turn-helix DNA-binding motif. It is predicted that CopY
might possess a similar elongated structure.
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stabilization, but may increase its affinity when metal is bound49. It is composed of
Asp101 and His103 from one monomer and His114 and Glu117 from the other, similar to
other repressors from the ArsR/SmtB family17, 48, 49. From the perturbation of DNA
induction16, 36, 44, 49. Its close homolog ArsR contains an N-terminal regulatory site
assignment, opposite compared to SmtB16, 44, 45.
CopY is a Zn(II) requiring Cu(I)-sensing repressor protein, where a motif of
cysteines coordinate bound metal to its C-terminus. Ligands responsible for Zn(II)
coordination to SmtB are not exclusively cysteinyl in nature51, 52. As in zinc finger
repressors, a homo- or heterogeneous composition of ligands exists to bind Zn(II), which
includes histidine, glutamic acid, aspartic acid or cysteine47. SmtB possesses an array of
residues responsible for zinc sequestration47, 51. Upon induction of an apo dimeric SmtB
via excess Zn(II), the newly coordinated metal displaces the metallated dimer complex
from the smtB/A promoter47, 51. Like CopY, SmtB obeys similar mechanistics in terms of
its ability to sense Zn(II) and activate its metabolism. Contrarily, SmtB does not require
a pre-existing metal to occupy its metal-binding sites as CopY requires Zn(II) before it
can sense high Cu(I) levels43.
The sampling of ArsR/SmtB family members indicates CopY’s close similarity in
terms of their ability to transfer the detection and coordination of metals into
conformational changes within protein quaternary structure which allows the cell to
maintain homeostatic equilibrium. In addition, each regulatory binding site coordinates
several different metal ions within the same location, albeit different geometry. The
differences between CopY and the ArsR/SmtB family lie within the starting, repressive
conformation of the regulating proteins, being predominantly apo prior to metal
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induction. Also, ArsR/SmtB repressors contain several binding sites, some produced
through the fusion of subunits which have been studied to be non-regulatory in nature.
The purpose of these metal-binding sites physiologically is largely unknown, but appears
to be a trend seen in all repressors that belong to the ArsR/SmtB family.

1.5. Significance Behind Metal-Controlled Dimerization
A small region of CopY’s dimer has been explored, but it is hypothesized that a
larger sequence spanning multiple regions harbors its interaction strength. However,
other forces are hypothesized to contribute affinity to CopY’s dimer aside from the
metal-binding site alone. As a metal-sensory repressor protein, CopY’s C-terminus may
be used in other scientific applications to bring normally monomeric proteins closer in
proximity through dimerization. The CopY sequence may possibly be used as a sensor or
diagnostic tool because of its inherent structural changes when Zn(II) is displayed by
Cu(I). Being able to provide a relevant contribution towards detailing the dimerization
properties of CopY’s C-terminus may lead its use towards a broader area of science.
Therefore, the characterization of a new dimerization tag can certainly have a dynamic
impact upon the field of protein-protein interactions research.
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1.6. Hypothesis and Specific Aims of this Research Project

It is hypothesized that both CopY’s metal binding site and
aliphatic repeat contribute to the formation of dimers.

I. Dissect the thermodynamics of CopY’s dimerization domain.
CopY’s dimerization domain will be fused to normally monomeric proteins to
establish its use as a dimerization tag. Therefore, through molecular biology, the gene
sequence for CopY’s C-terminus will be isolated from whole CopY and modified in
order to investigate the regions critical to the interaction. Its modification will involve
key deletions within its sequence that will further delineate which portions of the domain
are most important towards preserving dimerization.

II. Characterize a series of CopY deletion mutants for their ability to
form stable homo- and hetero- dimers in vivo.
Many combinations of mutations and deletions can be created within the CDG
sequence, but the ideal outcome is to assess if the cell can produce both homo- and
hetero-dimers in vivo. Fortunately, methods exist which allow for the indirect monitoring
of dimerization within the cell.
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1.7. Techniques Employed to Address Specific Aims
Many methodological approaches exist that are successful in studying the
dimerization of proteins, both in vivo and in vitro. The research presented in this thesis
was completed using two independent techniques that allowed for the analysis of the
formation, construction and composition of the metal-induced dimerizing C-terminus of
CopY. Isothermal titration calorimetry (ITC), an in vitro biophysical technique was used
to gain valuable thermodynamic results that describe the portions of CopY that contribute
to the formation of stable dimers55. Secondly, an in vivo technique referred to as proteinfragment complementation assays, allowed for the same CopY constructs being tested
with ITC, to be screened for their ability to form similar complexes within a live cellular
environment56. The assay also allows for the testing of both homo- and hetero-dimer
formation to gain valuable information as to exactly how CopY’s C-terminus dimerizes.
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Chapter 2
Materials & Methods

2.1. Materials
All materials utilized in this research were obtained of the highest grade or purity
unless otherwise noted. All chemicals were purchased through Fisher Scientific unless
otherwise noted. In addition, all liquid media, buffers and experimental solutions were
prepared with 18-MΩ Milli-Q® deionized water and prepared according to the general
principals presented in Molecular Cloning: A Laboratory Manual57. The CloneManager
Suite Version 6.00 software package (Sci. Ed. Central) was used for the visualization and
analysis of all DNA sequences. The BioEdit program was used to analyze DNA
sequencing data58. HIS-Tag affinity chromatography resin obtained from Sigma®.

2.2. Media
Luria-Bertani (LB) broth was prepared in 5x stock concentrations and diluted to a
1x working concentration upon culturing bacteria. The 5x stock solutions comprised 50 g
of tryptone, 25 g yeast extract, 25 g NaCl, 500 µL of 10M NaOH with the addition of
Milli-Q® water to 1 L. All media was autoclave-sterilized for 45 minutes at 121° C prior
to use for the bacterial overexpression of recombinant DNA clones57. SOC media was
prepared similarly, made in one liter quantities following the recipe outlined previously57.
Per liter, 20 g tryptone, 5 g yeast extract, 2 mL 5M NaCl, 2.5 mL 1M KCl, 10 mL 1M
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MgCl2, 10 mL 1M MgSO4 and 20 mL of 1M glucose were combined with the addition of
900 mM deionized, distilled water. The mixture was autoclave- sterilized for 45 minutes
at 121° C. It was used exclusively in the heat-shock transformation of known DNA
constructs and potential clones.

2.3. Spectroscopic and Calorimetric Instrumentation

2.3.1. Ultraviolet-Visible (UV-Vis) Spectroscopy
A Cary® 1E UV-Vis spectrophotometer was used throughout this research. The
UV-Vis was used for determining specific measurements such as plasmid DNA
concentration, elution profiles of purified proteins and reduced cysteine content within
proteins in solution.

2.3.2. Isothermal Titration Calorimetry (ITC)
A MicroCal MCS ITC instrument was used for conducting all dimer dissociation
experiments. A circulating water bath coupled to the instrument enabled control of the
experimental temperature. Having the circulator set 5° C below the experimental
temperature insured the instruments setting would not be exceeded. All experiments
were conducted at 25° C unless otherwise noted. All protein samples were degassed for a
minimum of 30 minutes with vigorous stirring at a temperature of 0.1° C below the
experimental temperature. Each experiment was programmed for 30 injections of 8 µL/
injection and an injector stirring speed of 400 rpm. The first injection was typically 2 µL
and was usually ignored due to dilution effects from the injection syringe. Injections
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were spaced out to dispense every 200 seconds, allowing for the strong dimerdissociation signals to retain back towards baseline before the next injection took place.
All protein samples were buffered in 50 mM Tris pH 7.8, 300 mM NaCl, and 0.01%(v/v)
β-mercaptoethanol added fresh prior to use. Data analysis of ITC experiments was done
using MicroCal’s version of Origin 7.0 software coupled with several advanced fitting
models including the dimer dissociation model. The dimer dissociation calculation is
programmed to fit single binding site model. The final values determined by the fitting
program produces a Kd and a ∆H for the entire reaction. The ∆H value represents the
total heat of the dimer dissociation reaction. Origin software calculates the quantity by
integrating the area between the raw spikes from the thermogram and the lower baseline
between each peak. Each determined value is an indicator towards the strength of the
dimer, where large Kd values correlate with larger enthalpies.
Initial concentrations of titrant dimer began at 1 mM for all proteins tested (Figure
2.1). High protein concentrations would insure the final concentration of protein within
the ITC cell would end sufficiently higher than the dissociation constant of the construct
being tested. Ideally, at the very end of an ITC experiment, with no dimer-to-monomer
transitions occurring, one would expect the raw thermogram to produce basal energies
signified only for the accommodation of more protein within the cell (Figure 2.2).
Dimer dissociation experimental data does not produce sigmoidally-based nonlinear fits like a ligand-macromolecule binding experiment would55. Dimer dissociation
experiments rely on the concentration-dependent gradient of dimer-to-monomer
transitions that occur throughout the titration because of the constant amount of protein
being injected within the cell. As the concentration of protein within the cell increases,
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approaching the dimer’s dissociation constant, progressively less dimer dissociation
occurs. As the experiment proceeds to the end, dimer from the syringe does not
dissociate fully when entering the cell, but remains predominantly dimer as the
concentration becomes markedly high within the cell. The equilibrium is shifted towards
the formation of dimers within the cell. At the endpoint of the ITC experiment, the
equilibrium state of the cell only detects the injection of concentrated dimeric protein
within a cell of the same, producing small energy signals as a result of accommodating
more protein.
ITC is heavily used to characterize the thermodynamics of macromolecule-ligand
interactions, but has recently expanded its to include macromolecular interactions59. The
idea of studying the reversible homodimerization of proteins was first described by
Velazquez-Campoy et al55. Detection of dimer dissociation was done through observing
the progressive titration of concentrated dimeric protein within an injection syringe, into
an adiabatic cell containing an identical buffer to the dimeric protein (Figure 2.1). At the
onset of the reaction, the largest amount of dimer dissociation to monomer is observed, as
indicated by the large, upward endothermic spikes in the thermograph. As the titration
progresses, a transition will occur where a decreasing amount of dimer dissociation
occurs within the cell because the protein concentration surpasses the interaction’s
dissociation constant. At the end of the titration, little dissociation occurs according to
the small set of spikes at the end of the thermograph. By calculating the area underneath
each spike which represents total energy from each dissociation injection, Velazquez-
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Figure 2.1. Theory behind Dimer Dissociation using ITC.
A schematic of the interior of an ITC cell and injection syringe is shown. The
syringe filled with dimeric protein (indicated by the letter D) placed within the
calorimetric cell of an ITC unit. As the experiment proceeds, monomer-dimer
equilibrium is established after every injection is dispensed within the cell. At the
beginning of an experiment, equilibrium is shifted greatly towards monomer
(indicated by M); as protein concentrations increase, the equilibrium gradually shifts
more to dimer as the dissociation constant is surpassed.
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Figure 2.2. ITC Data of the Reversible α-Chymotrypsin Dimer.
Typical dimer-dissociation reaction data is shown conducted by Velazquez-Campoy et al55.
Upper Panel: Concentrated dimeric protein is titrated into a stirred reaction cell of buffer.
The raw spectrum depicts the change in heat versus time as the sequence of injections occurs.
The upperward spikes indicate that the instrument supplies heat to the reaction cell because
the temperature decreases upon the dissociation of dimer, representative of an endothermic
reaction. The experiment was performed at 25°C. Lower Panel: Plot of the injection heat
observed versus concentration of α-chymotrypsin in the reaction cell. As the concentration of
protein increased within the reaction cell, a decrease in the dissociation of dimer is observed
as the concentration of protein surpasses the Kd of the protein’s monomer/dimer equilibrium.
The data obtained from this experiment agrees with previously reported analytical
ultracentrifugation data of the same dimer dissociation model60.
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Campoy et al. show that the total enthalpy of the reaction along with the reaction’s
dissociation constant can be obtained55.
To facilitate the correct calculations when fitting all dimerization data, dilution
effects were subtracted away from all experimental CDG data. Usually buffer dilution
effects are subtracted from experimental data through running separate control
experiments of similar injection volumes of buffer into a cell filled with identical buffer.

2.4. General Molecular Biology Methods
2.4.1. Plasmid DNA Purification, Determination of Concentration and
Purity
The principal method of purifying plasmid DNA from bacteria was through a kitbased protocol produced by Promega®. Their Wizard® Mini-Prep kit operates through
the methodology derived from the well-known alkaline lysis method of plasmid DNA
purification by precipitating cellular proteins, organelles and membranes while leaving
plasmid DNA soluble in the lysate. Preparation of plasmid DNA begins through
harvesting 3-5 mL of a saturated bacterial cell culture containing a plasmid-of-interest via
centrifugation (usually 5000 x g for 10 minutes using a 15- or 50-mL centrifuge tube).
The LB broth was decanted from the cell pellet where 300 µL of a resuspension solution
(50 mM Tris, pH 7.5, 10 mM EDTA, 100 µg/mL RNase A) is added to both resuspend
the cell pellet and to degrade any RNA molecules that may bind or interfere with
subsequent experiments involving the purified plasmid. The suspension was transferred
from the centrifuge tube to a 1.5 mL microcentrifuge tube.
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Next, the resuspended cells were lysed by adding an equal volume of 0.2 M
NaOH and 1% SDS to the prep. The tube was capped and inverted gently several times
to mix the solution. The addition of 300 µL 1.32 M potassium acetate, pH 4.8 will
precipitate cellular debris and most protein into a white precipitate upon capping the tube
and inverting the prep several times without vortexing. By centrifuging the preps at
10,000 x g for 8 minutes in a microcentrifuge tube, all cellular debris was pelleted
allowing one to separate the desired soluble plasmid DNA from the precipitate. The
lysate can then be applied to 1 mL of a silica-based Wizard® DNA Purification resin.
The mixture of lysate and resin is placed within a 3 mL syringe attached to a minicolumn via a luer-lok. The addition of 2 mL of 80 mM potassium acetate, 8.3 mM Tris,
pH 7.5, 40 µM EDTA, 55% ethanol after the lysate/resin mixture was passed through the
mini-column will aid in washing the resin. Elution of the plasmid DNA was done using
sterilized water or TE buffer.
Analysis of the purity and concentration of plasmid DNA preps was completed
spectrophotometrically. At a wavelength of 260 nm, the base-stacking of doublestranded DNA absorbs light, so one is able to directly determine concentration in ng/µL.
Fifty µg/mL of plasmid DNA produces an A260 of 1.00, therefore measuring the
absorbance of a purified prep allows one to determine concentration. In addition, purity
of a plasmid prep can be assessed through measuring the A260/A280 ratio using a UV-Vis
spectrophotometer. The ratio indicates the relative amount of plasmid DNA versus the
amount of protein within a preparation. Ratios of 1.60-1.80 indicate high plasmid purity.
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2.4.2. Preparation of Competent Cells
The following E. coli strains were obtained from Stratagene®: BL21, XL-1 Blue.
The following E. coli strain was obtained from Novagen®: Rosetta2(DE3). BL21 cells,
along with XL-1 Blue cells were used as a general cloning host throughout steps where
cloning methods were to be completed. Rosetta2(DE3) cell lines were used for
completed plasmid constructs to overexpress protein in which they encode when grown.
XL-1 Blue (Stratagene) competent cells were used in mutagenesis experiments because
their transformation efficiency was higher than that of the BL21 cells.
Chemically competent cells were made using the Rubidium chloride method57.
Rubidium-chloride competent cell preparation was applied for the entire array of cell
lines used with the exception of XL-1 Blue “Supercompetent” cells (Stratagene).
Preparation begins by culturing the desired cell line in 2 mL 1x LB media overnight. The
saturated culture was used as 1% innoculant for a larger 200 mL culture was grown at 37°
C until the OD600 reaches 0.4. The cells were then harvested by centrifugation at 5000 x
g for 10 minutes. The cell pellet was decanted and resuspended with 80 mL filtered, icecold 30 mM potassium acetate, pH 5.8, 10 mM rubidium chloride, 10 mM calcium
chloride • 2H2O, 50 mM manganese chloride, 15% (v/v) glycerol. The suspension was
placed on ice for one hour upon which the suspension was harvested via centrifugation at
5000 x g for 10 minutes. The cell pellet was decanted and resuspended with 8 mL
filtered, ice-cold 10 mM MOPS, pH 6.5, 75 mM calcium chloride, 10 mM rubidium
chloride, 15% (v/v) glycerol. The suspension was left on ice for 2-6 hours. The
competent cells were aliquotted, either by 20 µL per 600 µL microfuge tube for
immediate use, or by 1 mL aliquots stored in 1.5 mL microcentrifuge tubes to be re-
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aliquotted later. Aliquotted cells were kept on ice until the competent cells were “quickfrozen” using a -78° C bath with dry ice and either methanol, ethanol or isopropanol.
Upon quick-freezing, all aliquots were placed in a -70° C freezer until used.

2.4.3. Transformation of Competent Cells
The procedure for transforming competent cells was undertaken utilizing the
specifications from each cell strain’s vendor and not according to the protocol provided
with the rubidium-chloride method of achieving chemical competency. The most
important specification to follow in transforming competent bacteria is to “heat shock”
each reaction at the specific temperature and time interval outlined by the vendor. For
Novagen competent cells such as Rosetta 2 (DE3) cells, a 30-second heat-shock was
performed at 42° C whereas Stratagene recommends the same temperature but at a
longer, 45-second interval.
Each transformation began by transferring frozen aliquots of competent cells
directly to ice from the freezer. Each aliquot was handled by avoiding touching the body
of each microfuge tube containing an aliquot of competent cells and to handle them by
touching the tube top. One microliter of plasmid was transferred to each transformation
reaction and let incubate for a minimum of 5 minutes, but for no longer than 30 minutes.
At which time, heat-shock was facilitated by programming a PCR machine soak file for a
constant 42° C. Immediately after the heat shock step, each reaction was transferred back
to ice for a minimum 2 minutes before the addition of 100 µL of SOC media. SOC
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media is usually provided by the vendor but can be readily prepared and autoclaved. The
reaction was then transferred to a shaking incubator set to 37° C and 250 rpm for 30-60
minutes. After incubation, each reaction was plated on 1x LB agar plates containing the
necessary selectable markers. Once the reactions were plated and all excess liquid has
been absorbed into the media, the plates were inverted and placed into a standing 37° C
incubator. Incubation times varied consistent with the strain of bacteria used. All BL21derived E. coli strains usually took between 12-16 hours to produce colonies, whereas
strains such as XL-1 Blue take at least 18 hours to produce colonies.

2.4.4. DNA Sequencing
All clones produced through the duration of this research project were verified via
DNA Sequencing of all resultant plasmid DNA constructs. The core facilities at the
University of Pittsburgh Department of Genetics and Proteomics are responsible for the
operation of the sequencing core facility. The core facility utilizes an automated
dideoxy-based Sanger method of DNA sequencing where they charge a base fee per
sequencing reaction61.
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2.5. PCR-Based Molecular Biology Methods
2.5.1. PCR Amplification of Target Genes and Topoisomerase-Based
Cloning
All thermo-stable DNA polymerase enzymes used were derived from Pyrococcus
furiosis. These polymerases, named “Pfu” polymerases, contain a C-terminal
proofreading domain which insures that the genes being amplified are correct and that
mutations associated with “Taq” based polymerases derived from Thermus aquaticus are
eliminated. In addition, Pfu-based enzymes do not leave a single adenosine overhang at
the end of a PCR product where Taq-based enzymes do.
All PCR reactions were carried out using a PerkinElmer® Cetus Thermo Cycler
and all PCR primers were synthesized by Operon Biotechnologies®. All gene sequences
were amplified using either Pfu DNA Polymerase (Stratagene) or Platinum® Taq DNA
Polymerase (Invitrogen). PCR products produced were either primarily in the restriction
digestion and subsequent ligation into a desired vector that had been digested with
enzymes producing similar “sticky” ends. Contrarily, other PCR reactions were directly
cloned into a topoisomerase-based cloning system called TOPO cloning. The pCR
TOPO 2.1 Cloning Kit (Invitrogen®) is a kit-based method of cloning PCR products
directly into a linearized plasmid where the cloning is facilitated by a topoisomerase
enzyme conjugated to the ends of the vector. Topoisomerase-based subcloning allowed
for the insertion of sequences into an intermediate vector instead of attempting low yield
restriction digestion of PCR products where the restriction sites were close to the end of a
DNA fragment. Hence, cloning a gene into an intermediate vector provided plenty of
sequence flanking an insert-of-interest so restriction enzymes could bind their recognition
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sites with higher efficiency. The cloned inserts are restriction digested and able to be
cloned into a final desired vector cut with similar enzymes.

2.5.2.

Site-Directed Mutagenesis

All site-directed mutagenesis experiments were performed using either the
QuikChange® Site-Directed Mutagenesis Kit (Stratagene®) or the Phusion® SiteDirected Mutagenesis Kit (Finnzymes/New England BioLabs ®). Pairs of degenerate
primers were designed with the help of the Clone Manager® (Scientific Education
Software) software program. Each set of primers consisted of one “forward” primer
proceeding in the 5’ 3’ direction whereas the other primer binds to plasmid DNA in the
opposite orientation. Regardless, each primer contained the desired base pair mutation(s)
that would produce the final clone. To help in the screening process for positive clones, a
restriction enzyme addition or deletion was often used in designing mutagenesis primers
where positive mutants could be screened by restriction mapping. All positive mutants
were confirmed by DNA sequencing.
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2.6. Plasmid DNA Constructs
2.6.1. CopY Dimerization Gene (CDG)
CopY possesses very high hydrophobicity, consequently making it poorly soluble
when expressed in vitro. To facilitate the isolation of large quantities for studies
requiring upper micromolar to low millimolar concentrations of protein, an alternative
DNA construct containing CopY’s dimerization domain was necessary. As previously
described, the CopY gene can be dissected into two putative domains: its N-terminal
DNA binding domain comprised of residues 1-61, and its “dimerization” domain which
includes residues 62-14515, 19. Based upon secondary structural predictions (Figure 2.3),
the aliphatic-repeat N-terminally adjacent to the metal-binding site produces three alphahelices62, 63. Because of its amphipathic nature, a two-stranded coiled-coil motif is
predicted with high probability spanning Helices 2 & 3 according to the COILS
prediction program (Figure 2.4)64. With these findings, the aliphatic-repeat will be
treated in a manner where each alpha helix will be studied to determine which support
dimer formation.
Given the limitations outlined above regarding full-length CopY’s solubility, a
synthetic gene was created. A modified CopY was engineered utilizing only its Cterminus with restriction-enzyme sets between alpha helices. The engineered construct
allowed for whole alpha helices to be deleted within the aliphatic repeat (AR). The new
construct, termed “CDG”, will provide large quantities of soluble protein in order to
address the specific aims of this research. As part of its design, CDG was separated from
the DNA binding domain and cloned separately as its own gene construct composed of
the aliphatic-repeat and the metal-binding site (MBS.).
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Figure 2.3. Secondary Structural Prediction Output for CDG’s Dimerization
Domain (Residues 61-145).
The particular prediction program used was entitled the Advanced Protein Secondary
Structural Prediction Server, or “APSSP262, 63.” The primary sequence for CopY was
obtained from the National Center for Biotechnology Information (NCBI) website
where the sequence from residue 61-145 was queried and the results are shown
above. Its sequence was altered to match that of CDG and then input into the
PSIPRED program. Green cylinders represent alpha helices (“H”), where three are
predicted within CDG’s aliphatic repeat and can be labeled from N- to C-terminus, 1,
2, and 3. Predicted random coil is indicated by “C” and beta-sheet is shown to be a
yellow arrow, or “E.” High probability of an accurate prediction is indicated by the
size of the “Conf” bars above the primary sequence.
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Figure 2.4. Quaternary Structural Prediction of CDG using the COILS Prediction
Server.
Using the 28-residue search window, the CDG primary sequence was queried using
the COILS server to predict coiled-coil formation64. The x-axis represents the length
of the sequence queried while the y-axis indicates probability. According to the
output above, there is greater than a 95% probability of coiled-coil formation from
residues 42-69 (residues 103-130 of full-length CopY).
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The pET19b (Novagen®) inducible bacterial vector was selected to house the
CDG synthetic sequence (Figure 2.5). It contains a 10x HIS-Tag that is Enterokinasecleavable. It also contains three cloning sites that allow for the cloning of genes that
encode for fusion proteins that will solubilize the CDG sequence. Lastly, its expression
system is controlled by the T7-lac promoter which is a powerful protein expression
system when protein production is induced through the addition of isopropyl β-D
thiogalactopyranoside (IPTG).
While preserving amino acid composition, three pairs of restriction enzyme
recognition sites; SnaBI, BsrGI and SalI were engineered within the aliphatic region of
CDG. The spacing of each pair aims to delete portions of the beginning, middle, and end
of the aliphatic region based upon CopY’s secondary structural prediction (Figure 2.3),
where the sequence closest to the metal-binding site is located at the end of the aliphatic
repeat (A.R.). Therefore, it is hypothesized that the aliphatic region closest to the metalbinding site is more critical towards stabilizing dimerization rather than portions less
proximal to it.
The additional restriction sites were engineered in a way that preserves the
domain’s amino acid identity by using a different codon for the same amino acid (Figure
2.6). To avoid problems with codon-bias for bacterial protein expression because of the
changes, all large-scale protein preparations utilizing the CDG sequence were cultured
using Rosetta 2(DE3) expression cells (Novagen®) which possess an extra plasmid
which contains the genes for seven rare tRNA codons. In addition, XhoI and SalI sites
flank the CDG’s aliphatic repeat which allows for the removal of the entire aliphatic
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Figure 2.5. Circular CopY Dimerization Gene (pCDG) Vector.
Depicted above is a representation of the vector coding for N-10xHIS-rEK-Flexible
Linker-C. The CDG gene construct was purchased from BioBasic, Inc. The “Amp”
element indicates the gene for beta-lactamase which provides bacterial resistance in
the presence of ampicillin. The bacterial origin of replication is represented by
“pBR322 Ori.” The synthetic gene was subcloned into a pET19b vector (Novagen®)
within the XhoI and BamHI sites. In order to attach a fusion tag to this construct, the
NdeI and XhoI pair of restriction sites would provide an in-frame fusion linkage.
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CopY
CDG

61-ALWTEQEGKKFIYHPAVSEMENVRSATENLFSHICAKRVGATIAD-103
1-ALWTEQQGKKFTYHPAVSEMENVRSATENLFSHICVQRVGATIAD- 42

CopY
CDG

104-LVEEATLTQEDVQQIMKQLNKKEPVETIECNCIPGQCECKKQ-145
43-LVDEATLTQEDIQQIMKQLNKKEPVETIECNCIPGQCECKKQ- 84

Figure 2.6. CDG DNA Sequence and Alignment of CopY and CDG’s Primary
Sequences.
The engineering of the CDG sequence produced a highly homologous sequence,
limiting drastic changes in CDG’s designed primary sequence. The three predicted
alpha helices are underlined. All changes in primary sequence are highlighted in
yellow. CDG is 94% identical in primary sequence to CDG and contains 98%
homology based upon the replacement of similar amino acids. CopY’s sequence
begins at residue 61 and continues through the remainder of the protein.
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region to assess the dimerization of the metal-binding site. XhoI and SalI when used in
cloning, produce the same cohesive ends, allowing the vector to be ligated back together.
Contributions of the metal-binding site alone can be completed by removing it and testing
the remaining CDG sequence. A single-nucleotide site-directed mutation before the first
cysteine in the metal-binding site will produce a STOP codon, creating a protein
construct that only comprises the aliphatic-repeat, effectively removing the metal-binding
site from the remaining CDG construct.
Figure 2.6 displays CopY’s primary amino acid sequence. It also displays the
CDG sequence and its overall similarity in amino acid composition to CopY after
engineering the three pairs of restriction enzyme sites. Figure 2.7 outlines in a schematic
representation, the many combinations of metal-binding site mutants linked to aliphaticrepeat deletions. The “SnaBI” restriction enzyme pair (Figure 2.7, dark blue box)
provides the ability to cut out the following CDG sequence in the beginning of the
aliphatic region: YALWTEQQGKKFTY where underlined sequence denotes secondary
structural prediction of alpha helical sequence. The middle aliphatic deletion is
facilitated through restriction enzyme cutting by BsrGI (Figure 2.7, middle, teal box). It
removes 21 amino acids: VQRVGATIADLVDEATLTQED. The final aliphatic deletion
is produced through restriction digestion with SalI (Figure 2.7, right side, light teal box)
which removes the following 23 amino acids: VDEATLTQEDVQQIMKQLNKKEP.
Each one of these constructs can be produced without a metal-binding site if desired.
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Possible Constructs
Without MBS

1.

Possible Constructs
With MBS

2.

3.
Metal Binding
Site

Figure 2.7. CDG Protein Constructs of Aliphatic-Repeat Deletions with and without
a Metal-Binding Site.
The color-coordination represents the CopY dimerization domain where each shade
of blue represents a predicted alpha helix that can be removed using molecular
biological methods. Each of its three alpha helices is numbered in order as they
appear within the sequence. CDG provides the ability for removal of one alpha helix
at-a-time using molecular biological techniques. Pictured in red is the cysteine-rich
metal-binding site. Also shown are all the combinations of CDG constructs with
mixtures of aliphatic-repeat deletions with and without an adjoining metal-binding
site.
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2.6.2. Fusion of CDG to a Solubility-Enhancement Tag (SET)
Initial expression tests of the CDG sequence encountered poor protein production.
Since CDG’s hydrophobicity was high, the genetic fusion of a solubility-enhancing tag
was required65. The possibility of using a small, highly structured fusion protein was
explored, such as the immunoglobulin binding domain of the streptococcal protein G, or
GB166. A larger protein such as maltose-binding protein (MBP) can be used for
biophysical dimerization studies because the size differences between monomer and
dimer are more pronounced than with a smaller fusion67. Upon testing the
overexpression and purification of both GB1-CDG and MBP-CDG, maltose-binding
protein (MBP) was selected because initial expression and purification results showed its
purity and overall yield to be greater. Furthermore, the MBP-CDG construct appeared to
be more suitable for ITC studies. A plasmid containing the gene sequence for MBP,
malE was purchased from New England BioLabs®. The subcloning of the malE gene
into the CDG plasmid was completed using flanking NdeI and XhoI sites. (Figure 2.8 and
Figure 2.9).
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Figure 2.8. malE-CDG Bacterial Plasmid Construct (pMBP-CDG).
A schematic diagram showing the synthetic CDG sequence fused with the malE gene
which encodes MBP. The malE- CDG fusion construct is pictured subcloned within
the pET19b bacterial expression vector (Novagen®). MalE was cloned using NdeI
and XhoI restriction enzymes to create an in-frame construct with CDG.
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Figure 2.9. Scaled Schematic Representation of malE-CDG Construct.
The fusion of the maltose-binding protein gene, malE, to the synthetic CDG sequence
is depicted above. Within the aliphatic-repeat are the three pairs of restriction digest
sites used to probe each predicted alpha helix and its possible dimeric character. The
translated product of this construct produces a 520 amino-acid protein with a mass of
57.3 kDa.
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2.7. Protein-Fragment Complementation Assays
Protein-fragment complementation relies on the re-construction of two halves of a
reporter enzyme that were originally separated and cloned as a fusion to dimerizing
sequences56, 68-71. The in vivo complementation technique only operates on the premise
of specific dimer formation since the refolding of any higher ordered structures will not
reconstitute an active reporter enzyme that is critical for cell survival and assay viability.
Typically, the assay is run like a two-hybrid assay, where cloned as a fusion to one
enzyme half is an independent dimerizing sequence that remains nascent and unchanged.
On the complementary enzyme half, you would clone as a fusion, various test sequences
or mutations of the original dimerizing sequence in order to test for the formation of
functional two-stranded dimers.
A bacterial-hosted assay, a mouse-derived dihydrofolate reductase (mDHFR)
enzyme is used as the reporter (Figure 2.10). Used within the agar of the bacterial M9based assay plates is a drug 5-(3,4,5- trimethoxybenzyl) pyrimidine- 2,4- diamine, or
more commonly, trimethoprim. It is a competitive inhibitor of bacterial dihydrofolate
reductase (bDHFR) that has approximately 10,000-fold higher affinity for it rather than
the mouse homolog. Therefore, the production of mDHFR is reliant upon covalentlylinked protein-protein interacters to each of its two domains (Figure 2.11). Dihydrofolate
reductase is directly responsible for the reduction of dihydrofolic acid to tetrahydrofolic
acid, which is used in the biosynthesis of thymidine phosphates. Such precursor
molecules made by the cell serve as building blocks for the creation of nucleic acids,
specifically DNA. Inhibition of the bacterial reductase enzyme would eliminate a cells
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Figure 2.10. Three-Dimensional Structure of the murine Dihydrofolate Reductase
Enzyme (mDHFR), PDB ID 2FZJ.
Rendered in JMol is the mDHFR enzyme in ribbon format with bound NADPH and a
derivative of trimethoprim in ball-and-stick format53, 72. The 5-(omegacarboxy(alkyloxy) derivatives of trimethoprim bind mDHFR with greater than 5,000fold higher affinity than standard trimethoprim. Trimethoprim is the acting inhibitor
used in protein-fragment complementation56, 71.
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survivability unless the mouse reductase is reconstituted through the dimerization of
attached protein sequences.
Since expression of these recombinant fusion proteins is IPTG-inducible, a
dimerizing pair will bring each linked enzyme domain within close proximity so refolding of the active DHFR enzyme occurs. The refolded mDHFR enzyme directed
through the dimerization of linked CDG sequences effectively supplants irreversibly
inhibited bDHFR, allowing the host bacteria to survive and form colonies. As an internal
control, it has been specifically shown that a PFC assay setup involving only the two
enzyme halves without any linked interacting sequences, or dimerizers, will not survive56,
68, 73

.
Since bDHFR is an enzyme necessary for bacterial survival and within the

complementation assay it is inhibited, the cells rely upon reconsituted mDHFR via
dimerization. Positive growth on each plate is indicative of the latter, creating a facile
method of indirectly testing and observing specific two-stranded protein-protein
interactions within live cells A visual representation of the assay dynamics can be seen
in Figure 2.11.
Two vectors, each containing either mDHFR[1,2]-Zip or mDHFR[3]-ZIP were
obtained from Dr. Stephen Michnick’s laboratory at the University of Montreal, Quebec,
Canada. The vector designations signify that the gene sequences for domains 1 and 2 of
mDHFR are cloned on one plasmid and the gene sequence for domain 3 of mDHFR is
located on the complementary plasmid. The rationale for dissection in this manner was
conducted based upon analysis of the full-length enzyme’s crystal structure (PDB:
2FZJ)72. The CDG sequence was fused to each of the two DHFR enzyme-fragments
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using restriction digestion with NdeI and XhoI. Subcloning was done by BioPioneer (San
Diego, CA). Completion of each assay utilized competent Rosetta2(DE3) cells
(Novagen). The addition of 100 ng per vector was made to each competent cell aliquot
on ice. After heat shock at 42°C for 30 seconds, cells were transferred back to ice,
followed by the addition of 200 µL SOC media. Each assay mixture was incubated at
37°C for 60 minutes in an orbital shaker. After incubation, each assay mixture was
centrifuged for 15 minutes, followed by a resuspension/wash step with ice cold 1 x PBS.
Resuspended cells were then centrifuged again and then the process repeated an
additional two times before plating. The plate media recipe is as follows: 0.4% glucose,
2 mM MgSO4, 0.1 mM CaCl2, 800 µg/mL casamino acids, 10 µg/mL thiamine, 1.2 mM
IPTG, 100 µg/mL ampicillin, 25 µg/mL chloramphenicol and 1.0 µg/mL trimethoprim56.
Completed assay plates were allowed to incubate at 30°C for 48 hours.
First, 8 g of agar and a small stir bar were placed within a one-liter bottle filled
with 400 mL of deionized water and sterilized for 45 minutes followed by 30 minutes of
slow exhaust. After sterilization, the autoclaved bottle was placed on a stir plate while all
added nutrients, casamino acids, and antibiotics were dispensed into a sterile 100 mL
graduated cylinder. The mixture of additives was brought to 100 mL total volume with
sterile 1 x M9 Salts. Upon cooling of the autoclaved agar to below 50° C, the 100 mL of
additives was added slowly, pouring down the side of the bottle avoiding the addition of
air bubbles. Once added, assay plates were poured and allowed to cool and solidify for 2
hours. Assay plates were stored at 4° C and typically used within a one to two week
timeframe.
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Concentrations of IPTG, additional ZnSO4 and trimethoprim were determined
empirically. A matrix of plate recipes varied in the concentrations of all the latter
components was conducted on the DHFR[1,2] CDG/DHFR[3] CDG complementation.
Concentrations of IPTG ranged from 0.1, 0.2, 0.5, 1.0, 1.2, 1.5 and 2.0 mM; Zn(II)
ranged from 0.5, 1.0, 1.5 and 2.0 mM and trimethoprim ranged from 1.0, 1.5, 2.0, 5.0 and
10.0. Quantities of each of the three different additives were added directly to the plate
before pouring. The remaining components including other antibiotics, salts and
casamino acids were prepared as already described. Upon cooling of the agar, the
salt/amino acid/antibiotic mixture was added to the autoclaved agar. The mixture was
then poured into the plates already containing the varied amounts of trimethoprim, ZnSO4
and IPTG. The preparation of plates, in addition to all transformations was completed at
one time. The varied mixture that produced the optimum amount of colony growth (225
colonies) upon the assay plate was 1.2 mM IPTG, 1.0 mM Zn(II) and 1.0 µg
trimethoprim.
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DHFR[1,2]

DHFR[3]
Protein Expression
of Transformed
Constructs

Specific dimer-directed
folding of two enzyme
domains

AmpR

Figure 2.11. Theory behind the Operation of Protein-Fragment Complementation
Assays.
Shown on the left-hand site, two plasmids harboring are shown, each possessing the
same CDG clone on its N-terminus (multi-colored arrow). The difference between
each vector is in its N-terminal fusion, shown to be one half of the reporter enzyme
murine dihydrofolate reductase. The assay begins with the cotransformation of equal
quantities of plasmid within competent bacteria. Upon plating transformed mixtures
on assay plates, IPTG-induced expression begins where the cell relies on the dimerdirected reassembly of a nascent murine dihydrofolate reductase since the E. coli’s
DHFR has been inactivated through TMP inhibition. Growth on assay plates
signifies that dimerization within the assay was successful.
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Chapter 3
Results
3.1. MBP-CDG Expression and Purification

3.1.1. Expression of MBP-CDG
Large amounts of soluble fusion protein were produced upon induction of
typically a four-liter bacterial culture containing the MBP-CDG pET19b vector. At high
induction conditions of 1mM IPTG supplemented with 1mM Zn(II)-sulfate, MBP-CDG
would appear proteolytically clipped upon purification of the HIS-tagged protein.
According to SDS-PAGE, three bands would appear when run: one at the expected
molecular weight of 57 kDa, along with a minor band visibly lying just below the 57 kDa
product (Figure 3.1). The third band would be present low on the gel and is predicted to
be the HIS-tag due to its small MW. The unwanted proteolytic clipping was found to
occur at the N-terminus of the protein at the Enterokinase K (rEK) proteolysis site which
separates the HIS-Tag from the malE fusion gene. There is evidence that the rEK site
was producing the cleaved product upon purification because induced rEK proteolysis at
room temperature for approximately 48 hours would only produce two bands: the desired
MBP-CDG at an estimated molecular weight of 55 kDa and the HIS-tag band at a very
low molecular weight (Figure 3.1).
The expression of the MBP-Zn(II)CDG construct needed to be altered to attain
soluble fusion protein that did not produce a cleavage product. Less strenuous induction
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conditions were tested to determine if non-clipped MBP-Zn(II)CDG could be produced.
Induction of fusion-protein production proceeded in a similar fashion where the
concentration of IPTG added was decreased to a final 0.2 mM in culture while
maintaining a sufficient usable pool of Zn(II) (1 mM) for MBP-CDG to sequester .
Induction was allowed to proceed for the 2.5 hours at 37° C. Results produced large
amounts of soluble, non-cleaved protein despite the much lower induction concentrations
(Figure 3.2).
Affinity purification could proceed using either of two different affinity protocols.
The most common form of affinity purification that produced the cleanest, quickest
turnover from lysed bacteria to pure protein was to use the HIS-tag based upon purity of
protein via SDS-PAGE. HIS-tags operate upon the binding of a nickel(II) nitrilo triacetic
acid complex bound to resin beads. The Ni(II) conjugated to agarose beads binds the 10x
HIS-Tag with high affinity. Elution conditions involved the addition of 250 mM free
imidazole to wash buffer which freed the HIS-tagged protein from the resin. In addition,
purification was regularly performed using gravity rather than employing a low-pressure
pump system. Regardless of method, HIS-tag affinity purification provided high purity.
Alternatively, MBP is itself an affinity tag and relies upon conjugated amylose
beads as a resin. The MBP binds maltose and other sugar derivatives such as amylose
with high affinity as well and allows for affinity purification of any MBP-fused protein,
similar to a HIS-tag. The HIS-tag method of affinity purification was selected because of
its rapidity of use since amylose resin-based affinity columns required a low-

50

1

2

3

4

5

Figure 3.1. Analysis and Purity of MBP-Zn(II)CDG Protein.
Pictured is a 12% Coomassie Blue stained Tris Glycine gel prepared according to the
Molecular Cloning Manual57. Lane 1: EZ-Run® Molecular weight marker (Fisher
Scientific, molecular weights from bottom to top in kDa: 20.0, 26.0, 36.0, 47.0, 85.0,
118.0); Lane 2: Pure, proteolytically clipped MBP-CDG when induced at 1 mM
IPTG; Lanes 3-5: Time dependent induced rEK digestion for removal of the Nterminal HIS-tag, samples taken at times t = 12 hours, 24 hours and 48 hours,
respectively.
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Figure 3.2. Pure MBP-Zn(II)CDG Fusion Protein using Lower Induction
Conditions.
Pictured is a 12% Coomassie Blue stained Tris-Glycine gel of pure MBP-Zn(II)CDG.
Lane1: EZ-Run® Molecular Weight Marker (molecular weights from bottom to top
in kDa: 20.0, 26.0, 36.0, 47.0, 85.0, 118.0); Lane 2: pure MBP-CDG protein (Lane 2)
using a lower induction concentration of 0.2 mM.
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pressure pump. In addition, Ni2+-NTA resins can be quickly regenerated since Ni2+ tends
to leach away from the resin beads but can be recharged utilizing the provider’s protocol.
Amylose resin was not reusable after 2-3 purifications. Most importantly, HIS-Tag
purification regularly provided high levels of purity as evidenced in Figure 3.2.
Protein quantification was done by assaying the protein’s reduced cysteine
content. Since each protein contains a total of four cysteines, the 2,2’-dithiodipyridine
assay can be used to determine the reduced cysteine content within solution74. Since the
MBP-CDG proteins are expressed and purified with bound Zn(II) within its metalbinding site, it is possible to calculate each protein preparation’s molar concentration
based upon its reduced cysteine content, assuming four reduced cysteines per mole of
protein.
Upon protein purification, dialysis was set up against 150 volumes of 50 mM Tris
pH 7.8, 300 mM NaCl, 0.01%(v/v) β-mercaptoethanol. Dialysis buffer was changed
once every 4-6 hours and repeated three times to insure the removal of imidazole. βmercaptoethanol acted as a reducing agent in solution which provided protein preps with
a longer half life, limiting zinc loss across the experimental period. When stored at 4° C
for greater than 10 days, the fusion protein slowly lost Zn(II) (unpublished observations)
and subsequently the cysteines would oxidize and the protein would become prone to
aggregation. Once the protein lost most of its Zn(II), subsequent attempts to re-titrate
metal failed because of the aggregation phenomenon.
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3.2. Results from Isothermal Titration Calorimetry Studies
3.2.1. Design and Approach
Isothermal titration calorimetry experimentation was the principal technique used
in this research to study the in vitro homo-dimer association and dissociation of the CDG
protein. Prior to investigating this particular model, it was important to begin work on
the instrument with a well-characterized homo-dimerization model to insure that the
logistics and data analysis proceeds smoothly. Bovine pancreatic α-chymotrypsin was
chosen as the working positive model. Alpha-chymotrypsin, a serine protease similar to
trypsin, exists as a catalytically inactive monomer. Dependent upon metabolic needs,
once the organism starts synthesizing large quantities of chymotrypsin, cellular
concentrations rise allowing the enzyme to dimerize and become active75, 76. Its catalytic
substrate binding pocket, formed through the dimer interface, is not able to process
degraded proteins.
Experimental results shown in Figure 3.3 mimic those published findings in cited
in Figure 2.2 of this dissertation. In addition, the calculated dissociation constant from
the experimental ITC run conducted was 47 µM compared to 53 µM found in the
literature55. These results provided confidence that the MicroCal MCS ITC was sensitive
enough to perform dimer dissociation reactions regularly with accurate analysis.
According to literature, high concentrations within the range of 600-900 µM are
necessary to produce the quality of data that could be successfully fit with a theoretical
dimer dissociation equation55. Figure 3.4 shows a final raw thermogram (upper panel)
combined with the non-linear curve fitting analysis (lower panel) of the dimer
dissociation of α-chymotrypsin at a starting concentration of 700 µM. The final
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Figure 3.3. Experimental ITC Data of Dimeric α–Chymotrypsin.
The α-chymotrypsin titration was programmed to dispense 25 equal 10 µL injections
with the exception of the first injection which is usually ignored due to dilution
effects from the injection syringe. Starting protein concentration was 622 µM.
Internal experimental temperature was established at 25° C. Upper Panel: Presented
is the raw thermogram of the titration of concentrated dimeric enzyme. Upward
spikes indicate an endothermic reaction where the instrument is providing positive
power to the cell to balance the loss of heat. Lower Panel: Each point contains the
integration of the area under each titration point, plotted versus molar ratio of
monomer to dimer within the cell. Origin® Version 7.0 software equipped with a
specific non-linear fitting macro for dimer dissociation reactions provided the data
analysis. The red fit line indicates experimental α-chymotrypsin results.
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fitting parameters produced the following results: dissociation constant 47 µM; enthalpy
of reaction 9.1 x 104 kJ/mole. Despite the visually poor curve fitting, the resultant data
corroborates previously reported results for the dissociation constant of the αchymotrypsin protease.

3.2.2. ITC Results of MBP-Zn(II)CDG Dimer Dissociation
A similar experimental setup was done for the MBP-Zn(II)CDG experiments
compared to those from the alpha-chymotrypsin experiments. Starting concentrations of
MBP-CDG began at a minimum of 1 mM and applied to all combination of aliphaticdeletions, metal-binding site deletions and point mutations within the aliphatic region.
Since the dissociation constants for those constructs are expected to be higher than that of
the MBP-CDG, larger initial protein concentrations will provide a better non-linear curve
fitting session. Results of the full length MBP-Zn(II)CDG protein indicate strong
dimerization, with a final dissociation constant of 89 ± 22 µM (Figure 3.2).
As a negative control, unfused MBP was tested alone without CDG using ITC
(Figure 3.5). At a similar starting concentration of 1 mM total protein within the
injection syringe, ITC was tested to prove that the MBP does not facilitate dimerization,
nor contribute to CDG’s dimerization. Small downward-pointing spikes indicate weak
exothermic heat produced as a result of protein dilution within an ITC cell full of buffer.
Comparison of this data with Figure 3.4 clearly indicates the difference between a
dimeric protein signature and a non-self-associating protein in ITC.

56

Figure 3.4. Experimental ITC Data of the MBP-Zn(II)CDG Protein.
Upper Panel: Raw thermogram displaying positive, endothermic peaks upon MBPZn(II)CDG’s dimer dissociating to monomer. Each ITC reaction has been
standardized across the duration of CDG mutants to generate 30 injections at 25° C.
The first injection is 2 uL and is considered erroneous because of dilution phenomena
occur upon placement of the injection syringe within the cell. Lower Panel: Nonlinear fitting using the same Origin® Version 7.0 software. The calculated
thermodynamic values of this dimer indicate a dissociation constant of 89 ± 22µM.
The ∆H of the reaction was calculated to be 159 ± 10.3 kcal/mole. Black lines of fit
indicate results from the MBP-CDG constructs.
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3.2.3. ITC Results of GB1-Zn(II)CDG Dimer Dissociation
We evaluated an additional fusion construct utilizing GB1 as a solubility
enhancement tag instead of MBP to show that a multitude of fusions can dimerize as a
result of the linkage with the CDG sequence. Experimental ITC runs of the GB1Zn(II)CDG purified protein produced dimers, but the interaction did not appear as strong
as that of MBP-CDG. At a similar starting concentration of 1mM GB1-Zn(II)CDG,
strong dimerization similar to the MBP-Zn(II)CDG was observed. The data analysis in
Figure 3.4 provided similar thermodynamics in reference to the determined dissociation
constant of 114 ± 37.2 µM compared to MBP-Zn(II)CDG at 89 ± 22 µM. Being
statistically similar to each other, a calculated increase in dissociation constant of the
GB1-Zn(II)CDG dimer may be contributed to the overall size of CDG’s attached fusion
protein and may marginally influence the strength of the dimer. Overall, the MBP-CDG
construct was selected for ITC biophysical studies because of the better data quality
obtained.

3.2.4. ITC Results of MBP-Zn(II)CDG without its Aliphatic Region
(MBP-Zn(II)CDG ∆A.R.)
Testing of the metal-binding site’s individual contributions to CDG’s
dimerization was imperative towards testing the hypothesis of the dimerization domain.
Enabled through the design of CDG, a simple restriction digest to remove the aliphatic
region, followed by re-ligation of the vector allowed for the creation of a
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Molar Ratio
Figure 3.5. Experimental ITC Data of Maltose-Binding Protein (MBP).
MBP was expressed and purified by itself and not as a fusion to CDG. Concentrated
MBP was tested using ITC to display that it was a monomer at high concentrations.
Experimental setup is consistent with the ITC setup from Figure 3.4. Concentrated
monomeric MBP was titrated into a cell of buffer, similar to a dimer dissociation
experiment.
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Figure 3.6. Experimental ITC Data of the GB1-Zn(II)CDG Protein.
Experimental setup of the GB1-fused with CDG was setup consistent with previous
ITC experiments described in Figure 3.4. The upper panel provides evidence of an
endothermic signal, indicative of dimerization. The non-linear fit in the lower panel
produces a dissociation constant of 114 ± 37.2 µM with a reaction enthalpy of 90.5 ±
16.1 kcal/mole
.
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construct that maintained the open reading frame of the metal-binding site with the MBP
gene. All methodology used to prepare the MBP-Zn(II)CDG ∆AR was consistent with
how MBP-CDG was purified. Upon measuring MBP-Zn(II)CDG ∆AR’s dimer
dissociation via ITC, it was apparent that dimer dissociation occurred, albeit weaker than
MBP-Zn(II)CDG (Figure 3.7). The dimer dissociation model produces a non-linear fit
for the aliphatic deletion, providing a dissociation constant of 234 ± 11µM compared to
that of 89 µM for MBP-Zn(II)CDG. In addition, enthalpy of reaction for the aliphatic
deletion is 50.7 ± 16.9 cal/ mole, which is one-third of the energy that was produced via
MBP-CDG. The intensity of the peaks at the beginning of the experiment performed are
comparable to MBP-CDG. However, comparing the differences between MBPZn(II)CDG and its aliphatic deletion in their respective non-linear fits, it is noticeable that
the slope of the aliphatic deletion curve is not as steep as that of MBP-CDG.

3.2.5. ITC Results of MBP-CDG without its Metal-Binding Site (MBPCDG ∆MBS)
A simplistic approach was afforded through the design of the CDG construct for
removal of the metal-binding site. For any aliphatic deletion or aliphatic point mutation,
an additional site-directed mutagenesis reaction can be done with degenerate primers
containing a single mutant that produces a “STOP” codon just before the first cysteine
codon within the CDG sequence. The addition of a stop-codon using site-directed
mutagenesis eliminated having to use restriction digestion and ligation methods to cut out
a small sequence which could be tedious.
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Figure 3.7. Experimental ITC Data of MBP-Zn(II)CDG ∆A.R.
The whole aliphatic region was deleted from the MBP-Zn(II)CDG construct in order
to test the metal-binding site’s dimerization capabilities in ITC. Experimental
conditions remained consistent with those in Figure 3.4. The nonlinear fitting
calculations for the data presented above produced a dissociation constant of 234 ±
11.0 µM. The enthalpic heat of reaction was 50.7 ± 16.9 kcal/ mole.
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Upon purification of this construct, a substantial portion of the prep became
trapped within the insoluble fraction. Multiple preps were required and combined to gain
enough soluble MBP-CDG ∆MBS to perform ITC since a percentage of the expressed
protein was insoluble according to SDS-PAGE. This further supports that the metalbinding site produces specificity towards directing association of specific dimers instead
of higher order non-specific quaternary structures. The results of the ITC run did not
produce stable dimers (Figure 3.8). Small, downward spikes within the raw thermogram
do not indicate dimer dissociation but depict a monomeric protein dilution pattern as seen
in Figure 3.5 for monomeric MBP.

3.2.6. ITC Results of Partial Aliphatic Deletions in MBP-Zn(II)CDG
The CopY gene has been split into two separate functional domains. Residues 161 are composed of CopY’s DNA-binding domain which shares high homology to other
known DNA-binding proteins such as λCro repressor. Therefore, the remaining half of
the protein, residues 61-144 was labeled its dimerization domain. The aliphatic-repeat is
composed of a total of three elongated alpha helices and the protein’s metal-binding site
at its C-terminus. Since prior in silico evidence supports that a portion of this region
behaves like a coiled-coil motif, the aliphatic region of the dimerization domain was
probed to investigate which portions are most important to dimerization.
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Figure 3.8. Experimental ITC Data of MBP-CDG ∆MBS.
The metal-binding site was removed from the MBP-CDG to test the aliphatic-repeats
ability to form dimers in vitro. The construct was created by introducing a single
point mutation before the first cysteine in the MBS to create a STOP codon. Purified
MBP-CDG ∆ MBS was analyzed using ITC similar to all other MBP-CDG variants
tested. All experimental conditions remained consistent with Figure 3.4.
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In relation to the three possible partial aliphatic deletions, the middle deletion
sequence is presented below. The second helix deletion was facilitated through the
restriction digestion of the MBP-CDG plasmid DNA with BsrGI for removal, followed
by re-ligation of the vector DNA to create the partial aliphatic deletion. ITC results show
that dimerization occurs, but with a sacrifice to the dimer’s affinity (Figure 3.9).
Calculated dissociation constant for this construct was 202 ± 70 µM with a reaction
enthalpy of 51.9 kcal/mole. These values are comparable to the MBP-Zn(II)CDG ∆A.R.
ITC measurements, possibly meaning that the second helix removed from the aliphatic
region is critical to the overall affinity of the CDG dimer.

3.3. Protein-Fragment Complementation (PFC) Results
3.3.1. Assaying of Experimental Positive and Negative Control Sets
A set of known interacting protein pairs, fused with the two DHFR enzyme halves
was provided through Dr. Stephen Michnick’s laboratory of the University of Montreal,
Canada. The known protein-protein interaction was of a pair of homodimeric leucine
zipper sequences. Since a portion of the original hypothesis stated that part of CDG
mimicked a coiled coil motif (Page 29), meant that protein-protein interactions largely
aliphatic in nature could operate consistently using this technique. According to the
literature available detailing protein-fragment complementation, the negative control to
perform would be to transform only one half of a DHFR enzyme and not both56, 71. The
assay should theoretically produce no colonies, but any residual colony growth will help
establish a threshold for discerning positively- and negatively-interacting sequences in
the assay56, 71.
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Figure 3.9. Experimental ITC Data of MBP-Zn(II)CDG ∆ Helix 2.
The mid-aliphatic repeat deletion of Helix 2 covers part of CDG’s predicted coiled
coil. All experimental setup for this construct was conserved consistent with Figure
3.4. Upon fitting the collected data towards the dimer dissociation model, the
dissociation constant for the mid-aliphatic deletion is 202 ± 70.0 µM, while the
enthalpic heat of dissociation is 17.4 ± 6.10 kcal/mole.
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The set of vectors received from the Michnick lab contained fused basic-region
GCN4 leucine zippers sequences derived from yeast. Upon cotransformation, plating of
assay mixtures and incubation for 48 hours, results show that the controls produced a
large number of colonies (Figure 3.10). As indicated, the negative control was to
transform a single PFC vector instead of both to show that both vectors harboring each
half of the mDHFR reporter are needed for cell survival within the assay. Experimental
results indicate low cellular survival (Figure 3.11), verifying the need for both vectors.

3.3.2. Experimental PFC Data of Full-Length CDG Homodimer
Two types of heterodimers can be formed when testing sequences within the
assay designed for this research. It is possible to have heterodimers in the fusion
sequence and heterodimers within the binding site. In every complementation assay
shown within this research, there will always be a heterodimer formed within the fusion
sequence, where each fusion sequence is represented through one DHFR fragment half.
What is of particular interest to this work is the creation of specific heterodimers in the
binding site, namely the CDG sequence, either by way of the aliphatic region, or through
the presence or absence of the metal-binding site.
The first set of assays performed investigated an array of homodimeric
combinations with respect to CDG’s dimerization domain. Full-length CDG sequences
were tested against each other, as well as the same aliphatic deletions, and so on.
Presented are the results for the full-length CDG complementation (Figure 3.12), where a
large number of transformants indicate a strong interaction occurring within the cell.
Weaker interactions between tested proteins indicate lower cell survival upon plating.
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Figure 3.10. Experimental Positive Control of the DHFR[1,2]/DHFR[3]-ZIP
Complementation.
Two control vectors containing one of each DHFR enzyme fragment fused to a “ZIP”
31-residue leucine zipper sequence. The ZIP sequence is derived from the GCN4
transcriptional activator from yeast. Each transformation mixture was dispensed
upon plates containing 1.2 mM IPTG, 1 mM ZnSO4 and 1 µg/mL trimethoprim and
incubated at 30° C for 48 hours.
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Figure 3.11. Experimental Negative Control of Single-Vector Transformation of the
DHFR[1,2] ZIP Non-Complementation.
Single transformation of one vector harboring a DHFR enzyme half fused with a
leucine-zipper dimerization motif produced five colonies. This negative assay
indicates that several colonies upon a plate is not a significant sign that proteininteractions are occurring within the cell. Experimental conditions mirrored those
from Figure 3.10.
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Performing a similar negative control to the DHFR-ZIP system was necessary to
do for the CDG system in order to establish a threshold for positive and negative
interacting partners, in addition to displaying the need for strong colony growth when
transforming both DHFR vectors. This was done by transforming DHFR[1,2]CDG alone
without its complementary DHFR[3]CDG partner (Figure 3.13).

3.3.3. Experimental PFC Data of Global CDG Homodimer Deletions
To assess the contributions of each segment of CDG’s dimerization domain,
specific deletions in the sequence can be created similarly to those for ITC studies. The
two most important CDG deletions to test using the PFC technique would be the fullaliphatic deletion and the metal-binding site deletion. All data displayed in the remainder
of this section is indicated via a colony count value, instead of repetitiously showing the
assay plates themselves. All results displayed as colony counts for all combinations of
homo and heterodimerizing assays are displayed in Table 3.1.
As indicated in Figure 3.12, the most robust assay combination was the
homodimeric combination of full-length species. As expected, the full-length CDG
homodimers produced an average of 259 colonies. Results from the full-length
homodimeric CDG assays coincided with the biophysical analysis of the same construct
using ITC. Its calculated results produced the strongest dimer tested at a dissociation
constant of 89 ± 22 µM. To preserve the parallel structure between techniques, similar
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Figure 3.12. Experimental PFC Data Representing Full Length [1,2]-CDG
Complementation with [3]-CDG.
A protein-fragment complementation assay was done using the two full-length CDG
constructs, each fused to either DHFR[1,2] or DHFR[3] lying on a separate vector.
Experimental conditions, along with the concentrations of IPTG, TMP and ZnSO4
remained constant from previous experiments done.
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Figure 3.13. Experimental PFC Data Representing Full Length [1,2]-CDG NonComplementation as a Negative Control.
Mirroring the setup of the complementation assay in Figure 3.11, only one CDGfused DHFR fragment plasmid was transformed. Experimental conditions were the
same for this assay as those that have been presented.
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homodimeric deletion constructs were tested in protein-fragment complementation assays
just as they were using ITC.
The full aliphatic deletion was created similar to the deletion made in the MBPZn(II)CDG construct. Upon creating both deletions in both DHFR[1,2] and [3] CDG
constructs, followed by transformation, there is a noticeable decrease in the colony count
on the assay plate. An averaged result of 109 colonies was produced, which aligns with
the results obtained when the same constructs were used in ITC. The percentage of
colonies produced from the aliphatic-deletion compared to those from the full-length
CDG assay corresponds to the dissociation constants measured by ITC.
The next global CDG deletion that was tested was the removal of the metalbinding site. The metal-binding site deletion construct, similar to ITC, tested the ability
of the lone aliphatic-repeat region to maintain dimerization in vivo. As described before,
similar molecular biology methods of creating the metal-binding site deletion were
employed. An average of 23 colonies resulted on the assay plates, indicating a low level
of dimerization and subsequently survival of the cells.
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DHFR[3]-CDG Constructs
CDG
∆ A.R.

CDG
∆ MBS

CDG ∆
Helix 1

CDG ∆
Helix 2

CDG ∆
Helix 3

259±35

86±18

19±11

227±26

99±13

75±13

CDG ∆
A.R.

78±19

109±7

0±0

122±11

69±8

86±10

CDG ∆
MBS

20±4

0±0

23±3

12±2

16±3

20±4

CDG ∆
Helix 1

214±23

98±10

18±7

201±15

84±12

117±13

CDG ∆
Helix 2

113±22

112±16

12±9

87±11

141±20

64±11

CDG ∆
Helix 3

91±12

87±19

25±6

95±12

70±15

133±21

CDG

DHFR[1,2]-CDG Constructs

CDG

Table 3.1. Protein-Fragment Complementation Assay Results of all Homo-and
Heterodimer Combinations.
All colony count combinations for the complementation assays conducted; all values
are averaged from triplicate runs shown with calculated error. Those boxes
emboldened on the diagonal represent homodimeric assays. All other combinations
are heterodimeric in the binding site and in the fusion protein whereas homodimeric
combinations are only mixed in the fusion protein.
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3.3.4. Experimental PFC Data of CDG’s Partial Aliphatic Homodimer
Deletions
Given that the complete deletion of CDG’s aliphatic-repeat produces a large
decrease in dimer affinity, it is necessary to further expound its sequence in an effort to
locate those portions critical to the interaction. The first deletion assay conducted was
the Helix 1 deletion furthest away from the metal-binding site. According to averaged
assay results, 201 colonies were produced. The results from this assay indicate that the
majority of CDG’s affinity is retained in the absence of this alpha helix, despite the small
decrease in colony output. These results match ITC results, displaying that the affinity is
negligibly perturbed when helix 1 was removed.
The central alpha helix to CDG’s aliphatic-repeat was the next region tested. The
restriction enzyme that facilitated its removal was BsrGI. According to ITC, its removal
aligned comparably to the removal of the entire aliphatic-repeat region, which
highlighted its importance within the dimeric interaction. In vivo assay results produced
analogous results with a colony count average of 140. Being a little stronger of an
interaction compared to the full aliphatic-deletion in this technique, additional features of
the aliphatic-repeat participate in dimerization.
The third helix, the metal-binding site’s nearest neighbor, was the last partial
aliphatic-deletion to be tested. Containing a small, shared sequence of amino acids to
those found in the second helical region, the overlap will help explain similar results to
the BsrGI sequence. Testing this aliphatic-deletion within the protein-fragment
complementation framework produced a similar number of colonies to Helix 2, 133.
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Having similar homodimeric results shows the importance of the third alpha helix to
dimerization, in addition to the second.

3.3.5. Experimental PFC Data of Full and Partial CDG Heterodimer
Deletions
All protein-fragment complementation experiments were constructed as fusionprotein heterodimers. Heterodimers can differ from homodimers when testing dissimilar
mutants in CDG’s dimer binding site Binding-site heterodimers have been tested using
different combinations of CDG linked to both DHFR[1,2] and DHFR[3]. Generally, all
combinations of CDG mutants that contained DHFR-CDG sequences with a metalbinding site produced stronger dimeric interactions in vivo compared to those lacking it.
General observations indicate that any heterodimeric combinations tested within
the aliphatic-repeat have lower colony counts compared to those homodimeric in nature.
The assay mixture of one Helix 3 deletion with a Helix 2 deletion shows that asymmetric
dimer construction in vivo can be perturbed compared to those symmetrically-formed
homodimers. Also, a mixture of a full-length CDG construct with a helix 1 deletion
produced lower than expected survivability. Based upon previous data eliciting helix 1’s
contribution to dimer formation, it was predicted that the combination would produce an
equal number of colonies when assayed. It appears that the spacing and size of each
CDG sequence tested may influence the eventual folding of each construct’s enzyme
fragment upon the other.
The strength of the heteromeric interactions varied widely based upon the
composition of the aliphatic repeat being tested. For instance, assays involving the full-
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length CDG (aliphatic-repeat plus metal-binding site) produced the strongest interactions
compared to those partial aliphatic-repeat deletions occurring closest to the metal-binding
site. Consistent with homodimeric data resulting from ITC and homodimeric proteinfragment assays, the metal-binding site is necessary to preserve strong affinity dimers.
One particular combination-of-interest involved one full aliphatic-deletion assayed
against a metal-binding site deletion. As expected, the combination did not produce any
noticeable colony growth, indicating that there is no cross-functional interaction between
alpha helices and the Zn(II)-bound metal-binding site in vivo.
Similar results were observed generally with any combination of deletions that
involved a construct without a metal-binding site. Seemingly all assays either involving
the loss of one or both metal-binding sites produced colony counts no larger than 25.
Congruent findings between techniques inarguably indicate that CDG’s metal-binding
site is responsible for the formation of stable two-stranded dimers both in vivo and in
vitro. This represents two phenomena; first that only parallel interactions between two
aliphatic-repeats or two metal-binding sites occur. Secondly, this reaffirms the assays
sensitivity where no false positives are detectable, meaning low colony counts as
observed with the metal-binding site deletions are verifiable results.
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Chapter 4
Discussion & Significance

4.1. Biophysical Examination of CopY’s Dimer using ITC
4.1.1. Analysis of Homodimeric CDG Constructs
Initial studies on the metalated MBP-Zn(II)CDG began with the full-length
aliphatic repeat + metal-binding site sequence. Titration calorimetry of this construct
produced an expected dimer dissociation response as seen in Figure 3.4, based upon both
the intensity of the raw thermographic data peaks and because of the strength of the
interaction indicative through the determined dissociation constant. The MBPZn(II)CDG constructs Kd was determined to be 89 ± 22 µM using a non-linear fitting
model for a dimer-dissociation reaction. A similar experiment combining the dimeric
CDG sequence with an alternative solubility-enhancement tag, GB1, produced results
comparable with the MBP fusion (Figure 3.5). Zn(II)-GB1-CDG produced a
thermodynamic dissociation constant of 114 ± 27 µM, making them very similar.
As noted in Section 3.2.3., a rationale as to the slight difference in dissociation
constant may be attributed to the size of the dissociating dimer. MBP-Zn(II)CDG being
three-fold larger than GB1-Zn(II)CDG would produce a larger endothermic response due
to the ITC cell and the buffering solution accommodating a larger volume of protein
compared to GB1. In addition, upon dissociation to monomer, a larger protein surface
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area is created, where increased hydrogen bonding of the buffering components to the
protein would be created.
An experimental control was setup to insure that the obtained clones MBP and
GB1 were not dimer-forming fusions. The GB1 protein was selected because of its small
(56 amino acids), globular nature and is quite different in structure compared to the larger
MBP. In separate experiments, each individual fusion without a linked CDG sequence
was tested within the ITC (Figure 3.5). Contrary to the thermographic signature
established by a dimer dissociation reaction, concentrated monomeric proteins simply
produced small, dilute, exothermic responses, all of equal intensity, indicated that each
fusion protein does not possess self-associating properties.
While progressing through the homodimeric CDG deletion studies with ITC,
comparison between the full-length metalated fusion protein and its full aliphatic-deletion
displayed differences in the dimer affinity. The dissociation constant for the MBPZn(II)CDG ∆A.R. was calculated as 234 ± 11µM, which is roughly 30% of the strength
as that of the full-length CDG dimer (Figure 3.7). In addition, a correlation is noticed in
the calculated reaction enthalpies for both tested proteins, where the enthalpy of the fulllength CDG dissociation reaction was also crudely three-fold larger than the aliphatic
deletion. To summarize, it appears as if the full aliphatic repeat contains a sizeable
contribution to the strength and affinity of the CDG dimer. This observation is not to
underestimate the importance of the metal-binding site in its ability to organize
quaternary structure. To gain better insight into what the metal-binding site’s
responsibility was within the dimerization mechanism, the setup was inverted where only
the aliphatic region in the ITC was examined instead of only the metal-binding site.
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The construct that identified the metal-binding site’s relevance to the dimer
interaction is named MBP-CDG ∆MBS. Because of the absence of the metal-binding
site, there was no bound Zn(II) coordinated in each CDG monomer. When examining the
raw thermogram, small exothermic peaks are noticeable where the peaks seem to increase
in intensity as the ITC experiment continues towards completion (Figure 3.8). The ITC
data coincides with previous studies examining aggregation phenomena where
exothermic contributions chracterize the interaction, as indicated through the raw
thermograph77, 78. Concentrated MBP-CDG ∆MBS was injected within the calorimetric
cell, and during the first initial injections, it appears as if this construct does not dimerize
as its small exothermic spikes coincide with a non-dimerizing protein. Since the whole
thermogram does not produce equally-sized exothermic spikes as they gradually increase
towards the termination of the titration, there must be other interactions occurring within
the cell, or possibly the syringe that contains the concentrated sample.
In general, the preparation of the MBP-CDG ∆MBS required a larger amount of
preparative-scale culture compared to other constructs that have the metal-binding site.
Because this observation was not due to a decrease in the in vitro expression of the
construct, it was largely due to its tendency to aggregate and become trapped within the
insoluble fraction of the protein preparation (experimental observation). The loss of the
metal-binding site failed to organize MBP-CDG monomers into specific dimers. Once
high enough concentrations of soluble MBP-CDG ∆MBS fusion were acquired for ITC,
the protein became aggregated and formed non-specific higher-order structures upon
concentrating the samples. These aggregated forms of MBP-CDG did not spontaneously
reform into specific two-stranded dimers as indicated during ITC (Figure 3.8), but the
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equilibrium was pulled strongly towards the formation of non-specific aggregates.
Because of the radical outcomes observed during the preparation and testing of this
metal-binding site deletion, the structural and functional features of the terminal metalbinding site in terms of building stable dimers are better understood. It appears that the
metal-binding site itself possesses affinity contributions to the entire CDG dimer, but is
required initial to establish specific monomer-monomer contacts. Presently, a functional
role as been established for CopY’s –CxCxxxxCxC- site apart from its duties related to
metal-sensing and operon control.

4.1.2. Analysis of Homodimeric Partial-Aliphatic Deletions
The whole aliphatic-repeat’s importance to the interaction has been displayed
where further detail can be gained through the testing of each deletion. Within CDG’s
aliphatic repeat was the capacity to delete regions of sequence in order to investigate their
roles in dimerization. Using a single restriction enzyme at-a-time, one portion of the
aliphatic-repeat could be removed so as to determine that sequence’s duty to fostering
dimeric interactions in its absence. The following order of restriction enzymes
corresponds to their location within the CDG gene sequence: N—SnaBI-BsrGI-SalI—C
where the SnaBI restriction enzymes eliminate the gene sequence for the first predicted
helix and the SalI restriction enzymes deletes Helix 3 (Figure 2.7 & 2.9).
In vitro testing of the Helix 1 deletion was not conducted since protein-fragment
complementation assay results indicated it was not a critical element to CDG’s
dimerization, therefore the first partial aliphatic-deletion tested was the MBP-Zn(II)CDG
∆ Helix 2. Being a segment of the aliphatic-repeat within the middle of the aliphatic-
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repeat, it was unknown how much dimer affinity was attributed to this portion. After ITC
testing, the results showed similar trends to the total aliphatic-deletion data based upon
comparison of the dissociation constants (202 ± 70 µM) and enthalpy of reaction values
(Figure 3.9). At this point, the first helix of CDG’s aliphatic repeat was ruled out as
contributory to dimerization, but the second helix contains important coiled-coil affinity
for dimerization.
Further comparison between the middle helix deletion and the total aliphatic
deletion (Figure 3.7) show that the initial injections of the concentrated Helix 2 mutant
sample was visibly less intense, despite maintaining a starting protein concentration of 1
mM. Secondly, after a 30-injection ITC experiment, the difference in peak intensity
between the first and last injections was smaller than that of the full-length MBPZn(II)CDG. Finally, the combination produced a poor dimer dissociation fit of the data
upon initiating a non-linear fitting session. Equivalent observations of poor dimer
dissociation data fitting have been noticed in many of the ITC analyses. Conversely,
these results and observations are attributable to an unquestionably weaker dimer. One
cannot ignore that the removal of 20-30 residue segments of a protein would not perturb
the overall folding of a fusion protein, even though the CDG sequence was engineered
with restriction enzymes around its predicted secondary structure. Nonetheless, the
removal of the second helix sequence, aliphatic in structure, perturbs dimer affinity
negatively in CDG, confirming the hypothesis that the region tested forms a pseudo
coiled-coil motif.
Without testing the MBP-Zn(II)CDG ∆ Helix 3 construct, it was determined that
its contribution to the dimerization of CDG was high. In both partial aliphatic deletions

82

tested, the third helical sequence was intact. Since a 10-residue portion of the Helix 3
sequence overlaps into the sequence of the second helix, a remaining gap of 12 residues
needing to be analyzed. The mutation was created in the protein-fragment
complementation assay framework, allowing for its testing in stable dimer formation in
vivo.

4.2. Molecular Biological Examination of CDG’s Dimer using ProteinFragment Complementation
Many questions surrounded how robust CDG’s specificity was regarding its
dimerization, specifically if heterodimer construction was possible, given the multiple
interaction binding sites that it possesses. Since CDG contains the ability to have
portions of the sequence removed for testing, an in vivo molecular biology technique can
be used to test combinations of binding-site heterodimers in their dimer forming
capabilities. The protein-fragment complementation assay was chosen because of its
high operational specificity towards dimerization and for its well-known low probability
of false-positive results. More importantly, the use of the same set of mutant constructs
from ITC studies as in this assay’s framework allows for parallel conclusions to be drawn
between the two, independent techniques.

4.2.1. Organization of Complementation Assay and Homodimeric Studies
The premise of this in vivo dimerization assay relies upon the reconstitution of
two halves of an enzyme, mouse dihydrofolate reducatase (mDHFR), which effectively
replaces bDHFR inhibited by trimethoprim. Initial studies using the CDG sequence
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involve its full-length sequence, the full-aliphatic-deletion mutant and the metal-binding
site mutant. Performing these three homo-dimerization assays established a window
where one could discern between strong-interacting partners and weaker ones. The
hypothesis combined with the ITC results, states that the strongest interacting sequence
would be the full-length CDG homodimer and the weakest being the metal-binding site
deletion. Results from the three assays run in triplicate indicated that the full-length
homodimer assay produced the strongest dimerization based upon the colony-counts on
each assay plate. The full-length CDG homodimer produced 259 colonies when assayed.
Variations of the CDG sequence were tested as homodimers initially, in a similar
manner to the ITC experimental setup. The full-aliphatic deletion, leaving only the
metal-binding site intact produced an assay cell count of 109 colonies, much less than
expected compared to the full-length CDG homodimer. It is apparent that the metalbinding sites alone produced stable dimers in vivo, albeit weaker than the full-length
CDG. The metal-binding site deletion, leaving only the full aliphatic-repeat, produced an
average of 26 colonies per assay plate, indicating even weaker dimerization. Appearing
to be only residual activity, one can rationalize that at the large IPTG concentration, a
subsequent large amount of protein is being produced. Of that large pool of
mDHFR[1,2]- and mDHFR[3]CDG ∆MBS protein within the cell, a very small
percentage actually produced specific dimeric interactions as evidenced by residual
activity and growth on the assay plate. Despite this finding, aggregation effects observed
in vitro using ITC coincide with the severe loss in cellular growth during the assay. If the
26 colonies observed on the assay plate was a false positive response, one would expect a
much higher colony count since other cellular proteins would be acting as activators
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instead of the test proteins. Because the protein-fragment complementation assay is
highly specific for dimerizing pairs of proteins, many non-specific and higher-order
quaternary structures are not visible in this assay. Therefore, ITC results may not depict
dimerization occurring in vitro for the MBS deletion due to aggregation, but a low
percentage of dimer does form within a cellular environment as evidenced by the PFC
data.
As a result, a window of visible dimerizing pairs has been established via colony
count in the assay setup, as well as a threshold where very low colony counts might be
questioned in its dimerizing capabilities. Based upon these results, it is of great interest
to further investigate the aliphatic-repeat region based upon the affinity lost when testing
its full-aliphatic deletion with this assay.

4.2.2. Analysis of Homo- and Heterodimeric Partial Aliphatic Deletions
in vivo
As was conducted previously, three segments of the CDG aliphatic-repeat can be
individually removed to test the ability for the remaining CDG sequence to dimerize.
The first construct tested was the ∆ Helix 1 sequence furthest from the metal-binding site.
Biophysically it was determined that this portion of the aliphatic-repeat did not contribute
any affinity to CDG’s dimerization based upon the largely retained affinity of the dimer,
not making it a vital participant in the interaction. According to the protein-fragment
complementation, the homodimer interaction between monomers with the same deletion
remained strong as predicted, but on average not as strong as the full-length protein. The
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agreement between the two techniques with regards to the Helix 1 mutant confirms it not
to be critical to dimerization.
The ∆ Helix 2 and ∆ Helix 3 deletions occur within a region of CDG’s aliphaticrepeat that is predicted to form a coiled-coil motif. According to the resultant assay data,
they statistically appear indistinguishable. Equivalently, prediction output from the
“COILS” server predicts the existence of one elongated coiled-coil motif along with
secondary structural predictions showing two alpha helices in the same area62-64. Upon
querying either of the single helix/deletions within the COILS server, the coiled-coil
motif is destroyed. Therefore, considering this finding, combined with the data
representative of the second and third helix deletions, there certainly exists a coiled-coil
or a “pseudo coiled coil.”
Upon analyzing CopY’s primary sequence, its aliphatic-repeat of leucines,
isoleucines, and valines are not regularly spaced out, contrary to other regimentallyspaced coiled coils and leucine zipper proteins. This fact, combined with its unique
ability to dimerize and shift conformations in the presence of different metals ligated
within its metal-binding site is what separates CopY from other similar repressors. The
specificity lies within its unevenly spaced β-branched residues and its polar amino acids
that appear to flank and protect the hydrophobic core of the dimer. The requirement for
evenly-sized and aligned monomers to interact with one another is crucial and it
influences the strength of the protein’s dimerization, which further outlines the specificity
of the interaction. But more evident is without the repressor’s C-terminal metal-binding
site, the direction of all the specificity within the aliphatic-repeat is lost, having a low
probability that the rest of the two-stranded dimer will form.
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4.3. Conclusions
By using a combination of biophysical and molecular biological techniques, the
regions contributing to CopY’s dimerization have been determined. The design and
implementation of a variant of CopY’s C-terminus within this research enabled ITC to be
employed as the principal physical technique. Despite the non-ideal fitting of the
resultant data, thermodynamic constants characteristic of all homodimeric combinations
of CopY’s aliphatic-repeat plus its metal-binding site were explored. The dominant
construct producing the strongest affinity was the full-length protein, where all aliphatic
deletions remained dimerized in the presence of the metal-binding site. Its removal
eliminated dimer formation of the lone aliphatic-repeat, producing non-specific
aggregates (Figure 3.8).
A complementary molecular biological technique named protein-fragment
complementation enabled those CDG mutants tested in ITC to be further analyzed under
physiological-like conditions. PFC also possessed the opportunity to create heteromeric
combinations of the CDG dimer in vivo to assess the specificity built within its sequence.
All homodimeric assay results correlated well with the ITC data in terms of dimer
strength and formation. All metal-binding site deletions, either homomeric or
heteromeric in nature, produced low growth results, indicating its equilibrium has
severely shifted towards an aggregated state. The MBS-deletion results correlate with
those from ITC, despite the residual activity observed upon the assay plates. In addition,
those aliphatic-deletions tested in heterodimeric assays globally produced lower active
growth complexes compared to their homodimeric counterparts. Symmetry of the

87

constructed dimer concerning the aliphatic-repeats composition in length influences the
specificity and stability of the dimer.
Over the course of this investigation, the contributions of the aliphatic repeat have
shown to behave like a coiled coil. Amphipathic in nature, the design of CDG operated
upon the hypothesis that a coiled-coil existed. Its design allowed for the rational removal
of regions of the aliphatic-repeat. Through studying combinations of deletions using both
techniques, it appears that the coiled-coil spans an adjacent 32-residue sequence Nterminal to the metal-binding site. Noticeable decreases in affinity when studying
homodimeric partial aliphatic-deletions combined with lowered growth responses from
PFC affirm that the two segments of the aliphatic-repeat compose its coiled-coil.
The most distinctive property discovered of the CopY dimer was the requirement
of its metal-binding site to provide guidance for the rest of the sequence to assemble. Its
ability to organize quaternary structure is highly apparent according to both
methodologies used. With the addition of the 13-residue metal-binding motif and Cterminus, a total 45-residue metal-controlled dimerization sequence has effectively linked
several otherwise monomeric proteins under a variety of conditions.
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Chapter 5
Future Research Directions

In this research, the metal-binding site’s specificity for initiating contacts between
monomers was obvious throughout the investigation behind CopY’s dimerization.
Further studies might involve which individual residues provide the specificity within the
–CxCxxxxCxC- metal binding site. Randomization of the spacer residues indicated by
“x” while maintaining the spacing of cysteines so as not to perturb metal-binding may
illuminate some further details into its dimerization mechanism. A similar set of
experiments would utilize the swapping of sequences found throughout nature in place of
CDG’s metal-binding site to determine if its functionality is conserved. Metal-binding
experiments involving Zn(II) and Cu(I) substitution within a series CDG chimeric
proteins. Metal-binding may be perturbed or enhanced depending on any allosteric
interactions from the intermediate residues from the chimeric sequences. Cysteinyl
sequences originating from human glutamate decarboxylase II, uncharacterized proteins
from Arabidopsis thaliana and Xenopus tropicalis, along with thousands of others
existing in nature would be potential candidates for a chimeric domain swap project.
In a parallel research project, one might care to investigate the specificity present
within CopY’s aliphatic-repeat. It is known that CopY produces specific two-stranded
dimers, but does the specificity reside within the metal-binding site based upon initial
recognition, or does it reside with a stabilizing coiled coil which typically possesses

89

specificity governing the formation of dimers, trimers, tetramers or other structures.
Substitution of a traditional coiled coil, an average alpha helix or random coil, in place of
CopY’s aliphatic-repeat would illustrate the amount of interaction specificity present
within the region.
To investigate the sequence of dimer binding involving how CopY’s folds
together, a kinetics study would be advantageous towards studying the rates at which a
full-length CDG dimer folds compared to a whole aliphatic-deletion. Such a study would
confirm the hypothesis which states that the metal-binding site initiates the dimerization
and organizes quaternary structure, which was a concluding theory based upon the results
reported in this dissertation.
Lastly, to further investigate the structure of the aliphatic-repeat, a circular
dichroism (CD) study of CDG and its derivatives would be useful. Able to monitor
secondary structural composition, CD would enable confirmation of the hypotheses
stating the alpha helical content of CopY. In addition, structural information could be
gained through pursuing crystallographic studies of CopY’s metal-binding site fused to a
solubility-enhancement tag. For instance, high protein concentrations and purity would
be necessary for achieving x-ray quality crystals for structural determination. Several
attempts have been carried out previously utilizing nuclear magnetic resonance (NMR) in
order to gain structural information with little success. Low resolution between
neighboring resonances indicates high flexibility within the metalated protein sample. It
appears structural determination efforts should be focused towards using x-ray diffraction
since other similar repressors such as S. aureus Cd(II)CadC and Zn(II)CzrA, S. elongates
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apo and Zn(II)SmtB and M. tuberculosis Cu(I)CsoR have had their structures solved
through it9, 42, 47, 54.
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